







Structural characterization of gene products from uncharacterized operons of  




Von der Fakultät für Lebenswissenschaften 
 
der Technischen Universität Carolo-Wilhelmina zu Braunschweig 
 
zur Erlangung des Grades  
 
eines Doktors der Naturwissenschaften 
 










































































1. Referent:  Prof. Dr. Wulf Blankenfeldt 
2. Referent:  Prof. Dr. Michael Steinert 
eingereicht am: 11.02.2015  

















































































































































































organisms" on" the" planet." During" the" ‘Great" Oxygen" Event’" (Schirrmeister" et" al.," 2013),"
photosynthetically"active"cyanobacteria"started"to"introduce"oxygen"into"the"atmosphere"
and"thereby"changed"the"environment"(Tice"&"Lowe,"2004;"Konhauser"et"al.,"2011)"(figure"
1)." Even" in" the" absence" of" sunlight" due" to" dirt" and" rock" hurtled" into" the" atmosphere,"
bacteria"species"were"able"to"produce"oxygen"(Ettwig"et"al.,"2010)."
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entire" body" (Mukherjee"&"Hooper," 2015)." Besides" the" number" of" beneficial" bacteria," a"
smaller"number"are"directly"pathogenic"to"human."In"contrast"to"advantageous"symbiotic"
living"bacteria,"pathogenic"bacteria"usually"grow" in"a"very"diverse"and"at" the"same"time"
rapidly" evolving" community." Short" generation" times" and" several" methods" of" genome"
modulation"allow"them"to" rapidly"adapt" to"new"environmental"conditions."Even" though"
bacteria"are"surrounding"us"every"day," the"human" immune"system" is"able" to"protect"us"
from"most" pathogenic" bacteria" by" several" stages" of" host" defense"mechanism." In" some"





Helicobacter* pylori" (Kusters" et" al.," 2006)," Campylobacter* (O’Donovan" et" al.," 2014),*




Recently" the" Infectious" Diseases" Society" of" America" (IDSA" U" http://www.idsociety.org)"
identified" a" clique" of" bacteria" that" manage" to" escape" lethal" action" of" antibiotics" by"
developing" sophisticated" resistant" mechanism" (Pendleton" et" al.," 2013)." Besides"
















known" as" hydrocarbon" utilizing" microorganism" (HUMbug)" causing" corrosion" of" fuel"
systems"and"water"pipes"(Yuan"&"Pehkonen,"2007;"Itah"et"al.,"2009)."With"their"metabolic"
versatility," Pseudomonads" utilize" compounds" that" are" highly" toxic" to" other" bacterial"
species,"such"as"xylene"or"toluene"(Adair"et"al.,"1969;"Williams"&"Worsey,"1976)"or"even"






is" a" serious" threat" to" the" immune" compromised" such" as" AIDS" patients" or" individuals"
suffering" from"neutropenia" (Bendig" et" al.," 1987;" Aloush" et" al.," 2006)" and" cystic" fibrosis"
(CF)."It"is"one"of"the"most"commonly"found"gramUnegative"bacilli"in"nosocomial"infections"
(Klevens" et" al.," 2007;" Hidron" et" al.," 2008)" responsible" for" more" than" 10%" of" all" cases"
(Aloush"et" al.," 2006)." Furthermore," it" is" the"most" common"pathogenic"bacteria" isolated"
from"patients" that"have"been"hospitalized" for"more" than"a"week" (Lessnau"et"al.,"2014)."
Additionally,"burn"victims"which"partially"lack"the"protective"skin"layer"as"well"as"patients"
suffering"from"cystic"fibrosis,"where"Pseudomonas"colonizes"the"thick"mucus"in"the"lungs,"
are" targeted" hosts" (Lyczak" et" al.," 2000;" Pendleton" et" al.," 2013)." Other" than" medical"
treatments" of" infections" caused" by" related" gramUnegative" bacteria," Pseudomonas*
aeruginosa"infections"are"more"demanding"and"severe."Bacterial"infection"and"virulence"is"




et" al.," 1998)" and" potentially" act" as" cytotoxin" causing" cell" death" (Hauser" et" al.," 1998)."
Elastase," phospholipase" and" polysaccharide" aliginate" are" secreted" during" all" stages" of"
infection" to" protect" the" pseudomonad" from" host" immune" response." This" enables" the"
bacteria" to" undermine" host" defense" while" striking" back" by" a" mechanism" called" “pack"





five" decades." Amongst" other" bacteria," Pseudomonas" became" resistant" to" many"
antimicrobials"(Roy"et"al.,"2010)."BetaUlactams"are"ineffective"(Bassetti"et"al.,"2013)"due"to"
the" bacteria’s" natural" resistance" mediated" by" multiple" extendedUspectrum" betaU
lactamases"(Ambler*class*A*to*D)"(Lister"et"al.,"2009;"Hakemi"Vala"et"al.,"2014)."Moreover,"
P.*aeruginosa"employs"a"sophisticated"set"of"multi"drug"efflux"pumps"(Ozer"et"al.,"2012;"
Morita" et" al.," 2015)" and" possesses" a" modified" membrane" envelope" that" enforces" an"
exclusion" limit" of" 500" Da" via" a" membrane" porin" (Livermore," 2002)." Some" strains" have"
been"reported" to"be" resistant" to"all" common"antibiotics"also" including"aminoglycosides,"





et" al.," 2014)." An" infection" can" result" in" a" life" threatening" outcome" since"Pseudomonas"
disseminates"by" the"bloodstream,"causing" inflammation" in"any"part"of" the"body" in" later"
stages"of"infection,"at"which"an"antimicrobial"treatment"is"almost"impossible"(van"Delden,"
2007;" Shorr," 2009;" Lessnau" et" al.," 2014)." Therefore," it" is" one" of" the" most" prevalent"
bacteria"in"nosocomial"infections"(Klevens"et"al.,"2007;"Hidron"et"al.,"2008;"Bereket"et"al.,"










complete" human" genome" (McPherson" et" al.," 2001;" Venter" et" al.," 2001)." With" the"




of" deposited" genome" sequences" by" at" the" same" time" significantly" lower" costs" was"





Profound' out8pacing' of' Moore's' Law' in' January' 2008' is' reflected' in' the' transition' from' Sanger8based' to' 'next8
generation''DNA'sequencing'technologies;'with'compliance'adopted'from'NIH'(www.genome.gov).'
"
HighUthroughput" sequencing" made" new" wholeUgenome" sequences" available" on" daily"
basis,"with"more"than"25"genomes"published"every"day"in"2013"(Pruitt"et"al.,"2002,"2012,"
2014;"Tatusova"et"al.,"2014)."Since"1995"the"exponential"growth"kept"steady,"and" if" the"















not" all," human" diseases”" remained" largely" elusive" (Wade," 2010)." Initially," scientists"
believed"that"by"sequence"analysis"they"would"be"able"to"ferret"out"the"roots"of"genetic"
diseases" including" Alzheimer’s" and" certain" types" of" cancer" (Evans" et" al.," 2011)." This"
euphorism"was" drowned"when" it" became" clear" that" knowledge" of" genetic" composition"
cannot"be"directly"reflected"to"treatment"of"disease."This"holds"true"not"only"for"the"result"
of" the" HGP" but" is" true" for" all" new" sequenced" organisms."Moreover," newly" sequenced"
genomes,"especially"those"of"procaryotic"organisms,"contains"40U50%"of"genes"flagged"as"
“hypothetical"proteins”"with"unknown"function"(Schnoes"et"al.,"2009)."This"also"applies"to"
Pseudomonas* aeruginosa," however," from" the" time" when" the" bacteria’s" genome" was"
sequenced" (NCBI" ref:" NC_002516)" (Stover" et" al.," 2000)" and" initial" genome" annotations"
were" carried" out," information" and" research" conclusions" were" gathered" in" one" online"
resource" database," the" Pseudomonas" Genome" Database" (www.pseudomonas.com)"
(Winsor"et"al.,"2011)."New"sequences"and"annotation"are"deposited"to"NCBI"as"well"as"are"
documented" in" the"Pseudomonas"Genome"Database" (Winsor"et"al.,"2011),"generating"a"
Pseudomonas"specific"annotation"database.""
Recent"genome"sequencing"projects"revealed"previously" inconceivable"details"about"the"
Pseudomonas* aeruginosa* genome." The" broad" metabolic" capacity" and" ubiquitous"
distribution" originates" from" the" genetic" repertoire" which" is" larger" than" the" human"
genome" (Tümmler" et" al.," 2014)." Common" amongst" all"Pseudomonas" species" are" about"
4000" genes," the" core" genome" (Römling" et" al.," 1995;" Spencer" et" al.," 2003)."More" than"
10.000"accessory"genes"are" found" in" several" strains" that" complement" the"genome"with"
soUcalled" regions" of" genome" plasticity" (Mathee" et" al.," 2008;" Klockgether" et" al.," 2011;"
Stewart"et"al.,"2011;"Valadbeigi"et"al.,"2014)"resulting"in"genome"size"variations"between"
5.5"and"7"Mbps"(Schmidt"et"al.,"1996;"Lee"et"al.,"2006).""
The" genome" of" Pseudomonas* aeruginosa" PAO1," the" most" commonly" used" strain" for"




proteins" and" that" are" usually" functionally" linked." The" P.* aeruginosa" PAO1" ORFs" are"
clustered"in"1139"operons"of"variable"size,"which"can"be"predicted"by"bioinformatic"tools"
with"high"precision"(Mao"et"al.,"2014).""
Amongst" all" the" ORFs," only" seventeen" percent" are" experimentally" characterized" in"
Pseudomonas*aeruginosa*PAO1."Furthermore," the" function"of"about"45%"of"all"genes" is"
annotated"according"to"experimental"demonstration"in"closely"homologous"organisms"or"
sequence" homology." However," closer" inspection" reveals" that" about" 2300"ORFs," 40%" of"




















(Finkelstein" et" al.," 1993)." In" fact," one" often" finds" starkly" differing" function" in" different"




by" structural" genomics" consortia" that" altogether" contribute" about" 40%" of" human"
parasites" structures" including" Pseudomonas* aeruginosa" PAO1" (Chandonia" &" Brenner,"
2006)"deposited"to"the"PDB."Most"of" these" initiatives"are"normally"not"pursuing" further"
experimental" characterization." Hence," the" Enzyme" Function" Initiative" (EFI)" (Gerlt" et" al.,"
2011)," a" collaborative" work" aims" to" investigate" enzyme" functions" by" an" integrated"
sequenceUstructureUbased" approach." Therefore" they" mostly" rely," apart" from" structural"
biology," on" highUthroughput" bioinformatics" and" computational" substrate" modelling,"
focusing"on"enzyme"families"with"known"function,"so"that"only"its"substrate"needs"to"be"
specified,"rendering"this"approach"feasible."However,"amongst"the"number"of"structures"
deposited" to" the"PDB" (317" structures," status" as" of" 21st" of" January," 2015)," only" a" small"
fraction"was"characterized"in"total.""




actual" conformation" which" is" adopted" while" binding" its" ligand." Furthermore," the"
physiological" relevant" interaction" partners," the" organisms’" “metabolome”," is" not" fully"
characterized," which" is" thought" to" contain" all" metabolites." Its" composition" cannot" be"
generalized"because"metabolism"is"highly"strain"specific."Until"complete"characterization,"
docking"calculations"rely"on"either"incomplete"databases"or"synthetic"compound"libraries,"
irrelevant" to" the" host’s" metabolome." Therefore," negative" results" could" either" be"
interpreted" as" a" nonUsmall" molecule" binding" protein," or" simply" that" its" ligand" is" not"
represented"in"the"ligand"database"used."Moreover,"protein"conformations"determined"in"









final" goal" is" to" enlighten" a" significant" part" of" uncharacterized" genomic" ‘white" space’" is"
desired.""
Similar"approaches"however,"exclusively"focusing"on"Pseudomonas*aeruginosa*PAO1*have"
been" established" already," showing" the" relevance" of" the" bacteria" in" medicine" and"
biotechnology." These," however," always" imply" certain" restrictions." For" example," the"
AEROPATH" initiative" (www.aeropath.eu)" focuses" on" genes" proven" to" be" essential" for"






Instead" of" characterizing" single" genes," the" new" approach" aims" to" annotate"
uncharacterized"operons"first."With"the"gained"information,"elucidation"of"the"function"of"
each"gene"should"be"easier.""
An" interdisciplinary" approach" that" combines" knowledge" gather" by" structural" biology"
methods"with" information"drafted" from"metabolomics" to"derive"a"hypothetical" function"
of" the" operon" which" can" be" confirmed" by" biochemical" experiments" and" subsequently"
leads" to" new" genomic" annotations." The" general" workflow" involves" bioinformatics,"







For" the" left"side,"covering"metabolomics,"mutant"strains"need"to"be"generated" in"which"
one" of" the" investigated" operons" has" been" deleted" or" is" overUactivated." Comparative"
metabolome" analysis" of" these" lackKofU" and" gainKofUfunction" mutants" might" reveal"
differences" and" therefore" identify" a" metabolite." This" can" then" be" interpreted" in" the"
context"of"the"crystal"structures"of"the"gen"products"encoded"in"the"operon."Information"
from"both"branches"combined"will" lead" to"a"hypothesis" for" the" function"of" the"operon,"
which"will" then"be"corroborated"experimentally."Multiple"experimental"methods"can"be"














nosocomial" infections." The" strain" PAO1" used" in" this" study" comprises" a" rather" large"
bacterial" genome" of" ~6.5" mega" bases," coding" for" 5678" open" reading" frames" (ORF)," of"
which"40%"are"not"annotated"to"any"specific"function."Other"than"in"eukaryotes,"bacterial"
genomes"are"clustered"into"operons,"with"functionally"linked"genes"coUtranscribed"as"one"
polycistronic" mRNA." The" genome" of" Pseudomonas* aeruginosa" PAO1" comprises" ~1200"
such" operons." This" simplifies" the" problem" of" annotation." By" assigning" the" function" of"
operons" first," this" information" can" be" used" to" elucidate" the"molecular" function" of" the"
genes" included" in" this" operon" in" a" second" step." Furthermore," the" identification" of"
substrates" or" products" of" operons" is" thought" to" be" easier," as" intermediates" of"
physiological"pathways"are"hard"to"isolate"because"of"their"instability"and"short"lifetime."




2. Generation" of" knockUout" and" gain" of" function"mutant" strains" as" preparation" for"
future"metabolome"analysis"experiments"
3. Establishment"of"a"metabolite"extraction"method""
4. StructureUinspired" pilot" experiments" to" assess" the" function" of" structurally"
characterized"proteins"
'
Combined" information" from" both," detailed" structural" elucidation" and" knowledge" gain"












Chemicals" used" in" this" study" were" purchased" in" p.a." (pro* analysi)" quality" from" the"
following" companies:" Sigma" Aldrich" (Hamburg)," VWR" (Ismaning," Hannover)," Merck"

























































TB&–&Autoinduction&& 6g/l( Na2HPO4,( 3g/l( KH2PO4,( 20g/l( Trypton,( 5g/l( yeast(extract,( 5g/l( NaCl,( 10ml/l( 60%( glycerol,( 5( ml/l( 10%(glucose,(25ml/l(20%(lactose,(2mM(MgSO4(





35( g/l( trypton,( 20g/l( Yeast( extract,( 3.3( g/l( (NH4)2SO4,( 6.8(g/l( KH2PO4,( 7.1( g/l( Na2HPO4,( 0.5( g/l( glucose( 2g/l( lactose,(0.15(g/l(MgSO4,(5(ml/l(glycerol,(0.2x(trace(elements(
LuriaJBertani&(LB)& 10(g/l(tryptone,(10(g/l(NaCl,(5(g/l(yeast(extract(
YENB& 7.5(g/l(yeast(extract,(8.0(g/l(nutrient(broth(































50( mM( HEPES( pH( 8.0,( 300( mM( NaCl,( 1( mM( TCEP,( 10%(Glycerol(
Trace&metal&mixture& 1000x&
used&at&0.2&x&&

































Pseudomonas* aeruginosa" PAO1" genomic" DNA" was" extracted" based" on" a" standard"
protocol"from"Chen"and"coworker"(Chen"&"Kuo,"1993)"which"was"slightly"adapted."Briefly,"
2" ml" of" a" midUlog" growth" phase" bacterial" culture" grown" in" LB" were" harvested" by"




was" transferred" into" a" new" tube" and" the"DNA"precipitated"by" the" addition" of" 400µl" of"
100%"ice"cold"ethanol"and"the"mixture"incubated"at"U20°C"for"one"hour."Flocculated"DNA"
was"separated"by"centrifugation"at"4°C"for"20"minutes"and"was"then"washed"twice"by"the"





5"ml"E.coli" cell" culture" (XL1*blue" or"GC5)"harboring" the" target"plasmid"was"grown" in" LB"
media"supplemented"with"appropriate"antibiotics"overnight."The"plasmid"extraction"from"
harvested" cells" was" carried" out" with" an" alkaline/SDS" based" lysis" using" commercially"
available" plasmid" MiniUprep" kits" from" either" Qiagen" or" Omega" following" the" vendor’s"










which" DNA" could" be" extracted." This" became" redundant" by" the" invention" of" the"
polymerase"chain"reaction"(PCR)" in"1986"by"Mullis" (Mullis"et"al.,"1992),"allowing" in"vitro"
amplification" by" using" two" specific" DNA" primers," desoxyribonucleotides" and" a" DNA"
polymerase."Following"a"threeUstep"temperature"protocol,"starting"with"denaturing"DNA"
followed" by" temperature" lowering," generating" a" DNA" hybrid" between" annealed" primer"
and" single" stranded" DNA." The" 3’UOHUprimer" extension," carried" out" by" the" polymerase,"







primer" annealing" took" place" at" 56U65°C" (see" primer" table" 5," Appendix)." The" primer"
extension"at"72°C"was"carried"out"for"20U180"seconds"according"to"the"size"of"the"desired"
gene."Thirty"consecutive" repeated"steps" finalized"by"a"5"minutes" final"extension"step"at"
72°C"and"short"term"storage"at"10°C,"yielded"sufficient"PCR"product,"which"was"analyzed"
with" agarose" gel" electrophoresis" using" 1%" agarose" in" TAE" buffer" following" standard"
protocols"(Mullis"et"al.,"1992).""
Target" genes" from" Pseudomonas* aeruginosa* PAO1:" PA1621," PA1622," PA1623," PA1624,*
PA5506,*PA5507,*PA5508,*PA5509"were"amplified"using"appropriate"primer"sets,"designed"
according"to"the"published"genomic"sequence"of"Pseudomonas*aeruginosa*PAO1"(Winsor"



















Kit" (Qiagen)" following" the" supplier’s" manual." Amplified" gene" fragments" were" digested"
with"appropriate"restriction"enzymes"following"standard"protocols."Briefly,"1"µg"of"either"
purified"PCR"product"or"plasmid"DNA"was"mixed"with"1"µl" of" both"3’" and"5’" restriction"
enzymes"supplied"in"1x"reaction"buffer."Digestion"of"PCR"product"was"carried"out"at"37°C"
for" 60" minutes," while" reactions" containing" only" plasmid" were" supplied" with" 1" µl" of"
phosphatase"to"remove"the"free"5’Uphosphate"group"to"minimize"reUligation"of"linearized"
plasmid."Reactions"were"stopped"by"the"addition"of"DNA"loading"dye"prior"to"separation"
of" fragments" by" agarose" electrophoresis." Genetic" material" was" extracted" from" the" gel"
(QIAquick" Gel" Extraction" Kit)," purified" and" stored" at" U20°C" until" used" in" the" ligation"
reaction." Ligation"was" carried" out" in" 1x" reaction" buffer" at" 16°C" for" 4" hours." 100" ng" of"





























Plasmids" involved" in" Pseudomonas" aeruginosa" mutant" generation" were" sequenced"
following"a"standard"BigBye"based"protocols"(Heiner"et"al.,"1998)."100"ng"of"template"DNA"
were"mixed"with"4"µl"BigDye"(Life"Technologies)"and"1"µl"forward"or"reverse"sequencing"











The" QuikChange™" reaction" following" standard" protocols" (Braman" et" al.," 1996;" Liu" &"
Naismith," 2008)" was" used" for" sideUdirected"mutagenesis" to" introduce" point"mutations."
Two"primers"a"125"ng,"each"complementary"to"the"opposite"DNA"strand,"were"mixed"with"
a"template"plasmid."




hybrid" strand" consisted" of" one" parental" wild" type" strand" and" one" daughter" strand,"
carrying"the"desired"mutation."The"number"of"consecutively"carried"out"cycles"was"varied"
between" 12" and" 18" according" to" the" mutation" desired" (Table" 8)." Recognizing" and"
digesting"only"methylated"DNA"at" the" target" sequence"5UGAmTC," 20"units"of"DpnI"were"
added" to"digest"parental"DNA."Appropriate"negative" controls"were" transformed" side"by"
side"with"the"QuikChange™"reaction"mixture"into"competent"cells," incubated"and"plated"
on"LBUagar"containing"selecting"antibiotics.""
Table'8:'Cycling'parameters'according'to'the'type'of'mutation'desired'Type(of(mutation(desired( Number(of(cycles(Point(mutations( 12(Single(amino(acid(change( 16(Multiple(amino(acid(deletions(or(insertions( 18(((
"
4.2. Bacterial&transformation&J&general&aspects&
Bacteria" can" actively" take" up" external" plasmid" DNA" and" either" harbor" the" plasmid" or"
heritably"incorporate"it"into"the"genome"(Griffith,"1928;"Downie,"1972)."Genetic"diversity"
and" exchange" of" genetic" information" is" a" dynamic" process" involving" uptake" and" active"
release" of" DNA" containing" vesicles" (blebs)" within" a" culture" of" gramUnegative" bacterial"
species"including"Escherichia*coli"and"Pseudomonas*aeruginosa"(Dorward"&"Garon,"1990),"
both"used"in"this"study."The"presence"of"calcium"was"shown"to"be"important"to"bacterial"
competence" and" essential" for" uptake" and" exchange" of" genetic" material" (Cohen" et" al.,"
28"
"
1972," 1973;" Page" &" Doran," 1981;" Trombe" et" al.," 1992;" Trombe," 1993)." Nowadays" two"
methods" of" bacterial" transformation" have" been" established:" electro" transformation,"








10"ml" of" the" overnight" culture," incubated" at" 37°C" and" shaken." Cells"were" harvested" in"
sterile" chilled" centrifuge" bottles" at" an" OD600" of" 0.45" (Tu" et" al.," 2005)" and" immediately"
placed"on" ice." Supernatant"was"decanted"and"pellet" resuspended" in" 10"ml" sterile" fresh"
autoclaved" MilliQ" waterUcooled" to" ice" temperature" to" wash" the" cells" twice." The"







(Inoue" et" al.," 1990)." Briefly," a" one" liter" LB" culture" was" inoculated" 1:100" from" 50" ml"
stationary"phase"overnight"culture"and"grown"at"37°C,"200"rpm"until"an"OD600"of"0.3"(Tu"et"
al.,"2005)."Cells"were"harvested"and"first"resuspended"in"approximately"½"pellet"volume"of"
iceUcold" 100"mM"CaCl2," incubated" for" 10"minutes," harvested" and" resuspended" again" in"







Electroporation"was" performed" in" a" 1"mm" cuvette" applying" an" electric" pulse" at" 25" μF,""




with" the" appropriate" antibiotic." Transformation" of" the" product" of" a" ligation" reaction"
required"an"additional"desalting"step"via"micro"dialysis"as"elsewhere"described"(Saraswat"
et"al.,"2013).""
Chemical" transformation" was" accomplished" by" heat" shock" treatment" (Froger" &" Hall,"
2007)."10"ng"of"plasmid"DNA"was"added"to"an"aliquot"of"competent"cells"and"incubated"
for"30"minutes"on"ice."Heat"shock"was"achieved"by"transferring"the"tubes"to"42°C"water"
bath" for" 45" seconds." PreUwarmed," 1ml" SOC" media" was" added" and" the" cells" were"




Both* Escherichia* coli" and"Pseudomonas*aeruginosa*PAO1"were"grown" in" LB"media"with"







to" purify," however," obtaining" active" protein" then" typically" requires" proteinUspecific" and"
laborUintensive" in* vitro" reUfolding" steps"with"no"guarantee"of"biologically" active"product"
(Singh" &" Panda," 2005)." To" avoid" protein" aggregation," efficient" and" well" established"





were" developed." Thus," with" the" increasing" demand" for" novel" expression" techniques,"
expression" plasmids" featuring" novel" solubility" helper" are" desirable." In" this" work," tailor"
made" expression" plasmids" based" on" the" pETUsystem" (Studier" &" Moffatt," 1986)"




The" gene" coding" for" T7Ulysozyme"was" PCR" amplified" from" the" pLysS" plasmid" using" the"
primer" set" 5’UTTATAGCATATGGCTCGTGTACAGTTTAAACU3’" and" 5’U"





combined" in"5"ml" LB"broth"and" incubated"at"37°C,"180" rpm."After" four"hours,"plasmids"
were" recovered" (Qiagen" Mini" PrepUKit)" and" 1" µl" of" the" plasmid" mixture" was" used" as"
template"in"a"subsequent"QuikUChange"(Stratagene)"reaction."The"primer"set"used"in"this"
reaction"not"only" introduced"a"mutation"at" the" first"5’UNdeI" recognition"site" in"order" to"
only"leave"the"3’"original"NdeI"cloning"side"intact"but"it"was"also"designed"such"that"only"
plasmids" carrying" correctly" inserted" T7Ulysozyme" genes" were" amplified."DpnI" digestion"
following" supplier’s" protocol" was" carried" out" to" digest" parental" plasmid" DNA" prior" to"
transformation"into"fresh"XL*blue"cells."Cells"were"spread"on"agar"plates"and"incubated"at"
37°C"overnight."Single"clones"were"picked,"grown"in"5ml"LB"media,"and"the"plasmid"was"










nucleotides" coding" for" the" full" length" Prescission" protease" recognition" site"
(LeuGluValLeuPheGln|GlyPro;" |" =" indicating" the" cleavage" site)" (Cordingley" et" al.," 1990)"
were" ligated" into"p5$" linearized"with"NdeI." First," plain"primers"were"phosphorylated"by"
polynucleotide"kinase"following"the"vendor’s"manual."Namely,"a"30"µl"reaction"contained"
150"pmol"of"either"primer,"polynucleotide"kinase"buffer,"1"mM"ATP"and"5"units"of"enzyme"
was" incubated"at"37°C" for"30"minutes"prior" to"heat" inactivation"at"65°C" for"30"minutes."
Phosphorylated" primers" were"mixed" in" a" 1:1" ratio" and" heated" to" 95°C" for" 10"minutes"
using" a" PCR" cycler." Slow" primer" annealing" was" performed" by" walking" down" a" linear"
temperature" gradient" to" 20°C" over" a" period" of" 60" minutes." The" reaction" mixture" was"
stored"at"U20°C"until"use."The"template"p5$"was"linearized"using"the"single"cut"side"NdeI*at"
which"the"annealed"primer"dimer"was"inserted"using"regular"ligation"reaction."After"heat"
inactivation" of" the" ligase" the" reaction" mixture" was" desalted" by" microUdialysis" on" a"
nitrocellulose"filter"floating"on"ddH2O"for"20"minutes."Half"of"the"recovered"volume"was"




to" remove" the" 5’UNdeI" site" with" an" appropriate" primer" set" (table"WWW)." Digestion" of"
parental" plasmid" was" carried" out" by" DpnI," followed" by" transformation" into" chemical"









The" T4Klysozyme" gene" was" PCR" amplified" from" the" plasmid" pT4_lysozyme_D20A"




The" same" procedure" as" described" for" construction" of" p5$" was" followed." PCR" product"
insertion"into"the"linearized"plasmid"pet19mod*using"the"NdeI"recognition"site"followed"by"
a"subsequent"QuikChange"reaction,"resulted"in"the"plasmid"pCryst."Repeated"insertion"at"
the" XhoI" side" of" linearized" pCryst" also" followed" by" a" QuikChange" reaction" yielded" the"




















Heterologous" recombinant" protein" expression" and" purification" is" the" heart" of" protein"
crystallography" and" biochemical" studies" of" proteins." Versatile" organisms" have" been"
implemented"but"the"number"of"significantly"used"hosts"can"be"narrowed"down"to"a"few"







(Novagene)," restricts" the" plasmid" copy" number" to" 15U60" per" cell" (Bolivar" et" al.," 1977),"
while"slight"mutations"in"pMB1"resulting"in"the"pUC"origin"(pHERD"plasmids)"increased"the"
number"up"to"700"copies"/"cell"(Minton,"1984)."The"combination"of"replicon"and"promoter"
strength" dictates" the" number" of" translatable" polynucleotide" templates." The" promoter"
used"in"this"study"was"the"T7*promoter"(Mead"et"al.,"1986)"derived"from"the"T7*phage"in"
combination"with" the" phage" RNA" polymerase" (T7RNAP)." The" gene" coding" for" the" DNA"








this"study."These"cells"carry" the"plasmid"pLysS," from*which*a"natural" inhibitor"of"T7RNA"




1Uthiogalactopyranoside" (IPTG)" (Hansen" et" al.," 1998)." " This" yielded" soluble" and" pure"
protein," which" was" the"major" requirement" for" this" study." The" expression" temperature"
(Hewitt" &" McDonnell," 2004)" as" well" as" media" selection" were" shown" to" have" a" major"
impact"on"the"final"protein"yield"(Studier,"2005;"Sivashanmugam"et"al.,"2009)."To"identify"
the"best"combination"of"both,"all"constructs"used"in"this"study"have"been"testUexpressed"
using" different" media" and" various" expression" temperatures." Besides" refining" these"
physical"external"factors,"genetic"engineering"was"used"to"overcome"issues"of"imbalanced"
codon"usage" between" gene" donor" organism" (Pseudomonas* aeruginosa)" and" expression"
host" (Escherichia* coli)," which" could" result" in" premature" termination" of" translation." For"
instance" the" second" triplet" following" the" start" codon," shown" to" have" up" to" 15Ufold"
influence"on"gene"expression"level"(Looman"et"al.,"1987),"was"optimized"for"all"plasmids"
used"in"this"study."To"enhance"protein"expression"level"and"solubility,"the"SUMO"protein"
(Butt" et" al.," 2005;" Panavas" et" al.," 2009)" as" well" as" a" variant" of" the" greenUfluorescentU






In" all" cases," target" genes" were" expressed" in" various* E.* coli* strains." A" single" colony" of"
plasmidU"harboring"cells"was"used" to" inoculate"a"50"ml"overnight"culture" supplemented"
with"appropriate"antibiotic(s)"and"continuously"shaking"at"200"rpm"at"37°C."The"next"day,"
fresh" medium" was" inoculated" at" an" OD600" of" 0.02." Cells" were" grown" in" media"
supplemented" with" antibiotics" to" an" OD600" of" 0.7" at" 37°C," then" the" temperature" was"
lowered"to"20°C"and"0.5"mM"IPTG"was"added"to"induce"protein"expression."Cultures"were"
shaken" for" another" 14" hours." If" autoUinduction"was" performed," plasmid*harboring" cells"
were"grown"in"a"modified"auto"induction"medium"(AIUSTB)"supplemented"(Studier,"2005)"
with"antibiotics"to"an"OD600"of"0.5"at"37°C"before"the"temperature"was" lowered"to"25°C"
and" the" cultures" were" shaken" for" another" 36" hours." Cells" were" harvested" by"
centrifugation" for" 15"minutes" at" 6500xg." If" not" immediately" processed" further," the" cell"
pellet"was" transferred" into"a" falcon" tube," flash" frozen" in" liquid"nitrogen"and" stored"at" U
80°C"until" further"use."The" following" table"10"summarizes" the"expression"conditions" for"
the"different"genes."
""
Table'10:'Bacterial'expression'strains'and'plasmids'used'in'different'expression'conditions'Protein(( E.coli(strain( Plasmid( Medium( IPTG( Temperature( Time(PA1621( Rosetta2(DE3)pLysS( P10$& LB( 0.5(mM( 37°C([>(20°C(( 16(hours(PA1622( Rosetta2(DE3)pLysS( p10$& TB( 0.5(mM( 37°C([>(20°C( 14(hours(PA1623( BL21(DE3)pLysS( pOPINE_GFP& TB( 0.5(mM( 37°C([>(20°C( 12(hours(PA1624( BL21(DE3)pLysS( p10$& LB(((AI[TB( 0.5(mM( 37°C([>(20°C(37°C([>(25°C( 14(hours(36(hours(PA5506( BL21(DE3)pLysS( pET19mod& TB( 0.5(mM( 37°C([>(20°C( 14(hours(PA5507( Rosetta2(DE3)pLysS( pOPINE_SUMO& AI[STB( none( 37°C([>(25°C( 36(hours(PA5508( BL21(DE3)pLysS( p10$& LB( 0.5(mM( 37°C([>(20°C( 14(hours(PA5509( Rosetta2(DE3)pLysS( p10$& LB( 0.5(mM( 37°C([>(20°C( 12(hours(
"
4.4.3. Expression&of&selenomethionine&labeled&protein&&
Both," LUSelenoUmethionine" and" LUselenoUcysteine" is" suitable" replacements" for" their"
natural" amino" acids" to" perform" anomalous" diffraction" experiments" in" protein"
crystallography." In" this" study" LUselenoUmethionine" was" incorporated" by" using" minimal"





overnight" culture" supplemented"with" antibiotics," incubated" at" 37°C," 180" rpm." The"next"
day,"cells"were"harvested"and"resuspended" in"150"ml"M9"media"with"proper"antibiotics"
and" incubated"for"1"hour"further,"while"fresh"media"for"the"expression"culture"was"preU
warmed" to" 37°C" and" preUaerated" at" 130" rpm." Main" cultures" were" inoculated" with" an"
OD600" of" 0.01" and" continuously" shaken" at" 130" rpm," 37°C." The" optical" density" was"
monitored" every" hour" until" it" reached" 0.5." An" amino" acid" mix" to" inhibit" natural"
methionine"biosynthesis"was"added"(100"mg/l"K,"F"and"T;"50mg/l"I,"L"and"V)"and"growth"
continued"for"an"additional"20"minutes,"while"temperature"was"lowered"to"20°C"or"25°C"




Table'11:'Expression'details'of'selenomethionine'labeled'protein'E.coli(strain( Protein(( Plasmid( Media( IPTG( Temperature( Time(
Rosetta2(DE3)pLysS& PA1622( p10$& M9( 0.5(mM( 37°C([>(20°C( 16(hours(
BL21(DE3)pLysS& PA1623( pOPINE_GFP& M9( 0.5(mM( 37°C([>(20°C( 12(hours(
BL21(DE3)pLysS& PA1624( p10$& M9( 0.5(mM( 37°C([>(25°C( 12(hours(















chain."Based"on" this," the"concept"of" immobilized"metal"affinity" chromatography" (IMAC)"
was"developed"(Porath"et"al.,"1975)." In" this"study" IMAC"was"used"as"a" first"step"protein"








Cells" were" harvested" by" centrifugation" and" then" resuspended" in" buffer" A" containing""




HiTrap" Chelating" HP" column" (GE" Healthcare)" preUcharged" with" 100" mM" NiSO4" and"
equilibrated"with"buffer"A,"using"an"ÄktaPrime"System"(GE"Healthcare)."The"column"was"




gel" electrophoresis" and"pooled" together." The"protein" concentration"of" pooled" fractions"
38"
"
was" measured" by" UVUabsorption" using" NanoDrop" (Thermo)" and" the" proteinUspecific"
extinction"coefficient."Protease"was"added"to"remove"affinity"tags"during"dialysis" (Snake"
Skin," Thermo," 10" kDa" cut" off" membrane)" against" buffer" GF" at" 4°C" or" 20°C" overnight,"
depending"on" the"protein" purified." Precipitated"protein"was" removed"by" centrifugation"
(5000"g,"20"minutes)"and"the"supernatant"was"passed"over"a"HiTrap"Chelating"HP"column"
(GE" Healthcare)" preUequilibrated" with" buffer" GF" to" separate" uncleaved" fusion" protein"
from" tagUfree" target" protein." A" gradient" from" 0%" to" 100%" buffer" D" was" performed" to"
elute" taggedUprotease" as"well" as" uncleaved" protein" from" the" column." The" flowthrough"
and" the" collected" portions" were" analyzed" by" SDSUPAGE," fractions" containing" target"
protein" were" pooled" and" concentrated" by" ultracentrifugation" (Pall" Corporation,"





















! = !!! + ! ∗ !!!!!!!! "#ℎ!!!!!!! = 1 + 2! ! ! !!" !!!" − 2 ! """"""""""
The"distribution"coefficient"!"is"defined"by"the"analyte"radius"of"gyration"!,"the"average"
pore"diameter"of"the"matrix"material"!"and"a"general"adsorption"parameter"!"(Gorbunov"






Figure' 12:' Porous'material' of' SEC' columns' and' schematic' interaction' of' analyte'mixture'with' the' SEC'material' –'
resulting'in'a'different'column'retention'volume,'right'(adapted'from'(GE,'2010))'
"
A" concentrated" protein" solution" of" up" to" 12" ml" was" injected" onto" a" size" exclusion"





concentrated" via" ultrafiltration" (Pall" Corporation," Macrosep®" advance," 10"kDa)" for"
crystallization" experiments." The" protein‘s" molecular" weight" was" calculated" from" its"
retention" time" using" the" middle" of" the" UV" peak" against" a" standard" calibration" curve,"



















PA1621" 30471" UUU"""" 26930" UUU"
PA1622" 31290" 10" 26930" S26/60"75"""""
PA1623" 24924" 4" 35410" S26/60"75"""""""
PA1624" 27753" 10" 30940" S26/60"75"""""
PA5506" 30471" 10" 26930" S26/60"200"""""""
PA5507" 24262" 4" 18700" S26/60"75"""""""
PA5508" 47900" 10" 50015" S26/60"200""
PA5509" 24841" UUU"""" 30035" UUU"
&
4.5.4. TEV&protease&







crystal" structure" solved" in" complex" with" an" oligopeptide" substrate" (Phan" et" al.," 2002)"




direct" substrate" specificity" (Kapust" et" al.," 2002)." However," the"most" efficient" sequence"
was"ENLYFQ|S.""
The"drawback"of" commercial"TEV"protease" (LifeTechnology),"apart" from" its"high"cost," is"
that"it"cleaves"itself"after"time,"thus"specific"proteolytic"digestion"of"target"fusion"protein"
is" restricted" to" a" certain" time" frame." Therefore" a" mutant" of" TEVUprotease" (S219V)"
41"
"
reported"to"be" imperviously"resistant"to"autolysis" (Kapust"et"al.,"2001)"was"employed" in"
this" study." The" gene" coding" for" the" protease"was" genetically" fused" to"maltose" binding"
protein"(MBP)"increasing"expression"level"by"orders"of"magnitude."Sophisticated"plasmid"
design" was" carried" out" by" introducing" an" additional" TEVUepitope" recognition" site." The"
fusion" protein" is" undergoing" postUtranslational" autoUprocessing" by" cleaving" MBP" from"
itself," liberating"the"featured"His6Utag"which"is"needed"for"follow"up"protein"purification."
As" a" result" of" high"expression" level," fast" folding"of" TEVUfusionUprotein" induced"by"MBP,"
high"yields"of"pure"protease"could"be"obtained.""
In"detail,"4" liters"of"LB"media"supplemented"with"appropriate"antibiotics"was" inoculated"




was" separated" by" ultracentrifugation" and" soluble" fraction" was" loaded" onto" a" nickel"
affinity" column" (GE" Healthcare)" preUequilibrated" to" buffer" A." Column" was" washed"
thoroughly"with"buffer"A"supplemented"with"2%"buffer"B"until"UV"trace"reached"baseline"
after" washing" with" 50" ml." " A" continues" gradient" to" 60%" buffer" B" over" 240" ml" was"
performed" to" elute" the" specifically" bound" protease." Fractions" containing" pure" target"
protein" were" identified" by" SDSUPAGE," pooled" and" dialyzed" against" protease" buffer" (50"
mM"HEPES,"300"mM"NaCl,"1mM"TCEP,"10%"glycerol)"overnight."Next"day"a"size"exclusion"
chromatography" was" performed" using" a" 26/60" S75" column" (GE" Healthcare)" preU
equilibrated" to" the"same"buffer."Peak" fraction"contained"pure"protein"were"pooled"and"
concentrated" to" a" maximum" of" 3" mg/ml" using" ultra" centrifugation" (Pall" MacroSep,"
10kDa)."500µl"aliquots"were"flash"frozen"in"liquid"nitrogen"and"stored"at"U80°C"until"use."








common" cold" in" humans" with" worldwide" health" and" economic" impact" (Jensen" et" al.,"
2015)."Its"small"positiveUstranded"RNA"genome,"about"7200"nucleotides"in"size"(Stanway"




fact," 3C" protease" was" already" successfully" targeted" in" treatment" of" common" cold" in"
experimental"phase" (Matthews"et"al.,"1999)."Structural" characterization"of" the"protease"
(Matthews" et" al.," 1994)" revealed" a" trypsinUlike" fold" and" active" site" composition" but"
possessing" characteristics" of" both," serine" and" cysteine" protease"with" the" catalytic" triad"
CysU146,"HisU40"and"GluU71."The"protease"recognizes"an"epitope"stretch"of"minimum"six"
amino"acids"(TLFQ|GP;"|"indicates"the"cleavage"site)"(Cordingley"et"al.,"1990)."Studies"on"
amino" acid" composition" revealed" " that" the"peptide" recognition"pattern"of" EVLFQ|GPVY"
showed"the"highest"catalytic"activity"and"very"conservative"mutations"on"either"P4"or"P5"
dropped"Kcat/Km"by"orders"of"magnitude"(Cordingley"et"al.,"1990)."This"could"be"explained"








lysate" in" a" 2Ustep" manner" including" both" standard" metal" affinityU" and" size" exclusion"







SUMOylation" of" recombinant" expressed" protein" is" commonly" used" to" overcome"major"
issues"of"recombinant"protein"expression"and"insolubility"(Panavas"et"al.,"2009)."A"SUMOU
specific"protease"removes"the"smallUubiquitin"modifier"(SUMO)"from"a"target"protein"and"
facilitates" the" generation" of" protein" of" interest" with" a" native" NUterminus" from" an"
expressed" SUMOUfusion" protein." Other" than" the" previously" described" TEVU" or" HRVU3CU
protease" SUMO" protease" does" cleave" at" a" specific" epitope" sequence" but" rather"





its" natural" CUterminal" extended" precursor" form" (Hickey" et" al.," 2012)." The" optimal"
temperature" for" cleavage" is" 30°C;" however," the" enzyme" is" active" over" a"wide" range" of"







The" protein"was" purified" as" described" previously" (Garrity" et" al.," 2007)." In" short," pPNC2"
harboring" BL21(DE3)pLysS" cells" were" grown" in" lysogenic" broth" supplemented" with"
appropriate" antibiotics." Cultures" shaking" at" 37°C" were" grown" to" OD600=0.8," the"













into" a" chamber" (BioRad)" and" ethidium" bromide" was" added." The" polymerized" gel" was"
transferred"into"a"running"chamber"(Biorad)"flooded"with"TAE"buffer."DNA"samples"were"
mixed" with" an" appropriate" amount" of" loading" buffer" and" loaded" side" by" side" with" a"
suitable"DNA"ladder"onto"the"gel."Migration"of"the"samples"was"carried"out"at"15V"/"cm"
until" band" separation" was" completed" as" indicated" by" color" separation" included" in" the"
loading"buffer"dye."Results"were"examined"by"gel"documentation"using"a"regular"camera"




Sodium" dodecyl" sulfate" polyacrylamide" electrophoresis" was" performed" following" the"
method"of"U.K."Laemmli"(Laemmli,"1970)."SDS"gels"were"casted"following"standard"recipes"




mix"was" loaded" for" comparison." Electrophoresis"was" carried" out" in" SDS" running" buffer"
applying"60"mA"until" the"blue"dye" front"reaches"the" lower"edge"of" the"gel."The"gel"was"























blank" measurement" was" carried" out" using" the" solubilizing" solution" only." Protein"





A" previously" reported" coupled" assay" was" customized" to" test" PA5507" upon" its" activity"
using"different"amide"substrates"(Smith"et"al.,"2009)."The"assay"was"carried"out"in"20"mM"
PO4"buffer,"pH"7.3"using"200"µM"NADH,"3.3"mM"alphaUketoglutarate,"1.5"µM"LUglutamic"
dehydrogenase" (EC" 1.4.1.3," SigmaUAldrich)." All" substances" were" ordered" from" SigmaU
Aldrich"and"freshly"dissolved"in"water"or"50%"DMSO:water"v/v."The"reaction"was"initiated"









Pilatus2M" at" the" EMBL" BioSAXS" beamline" P12" at" the" PETRAUIII" storage" ring" (DESY,"
Hamburg)." Data" were" processed" with" the" ATSAS" suite" using" PRIMUS" (Konarev" et" al.,"






Other" than" eukaryotic" genomes," bacterial" genomes" are," to" a" large" extend" clustered" in"
operons" where" functionally" linked" genes" are" coUexpressed." These" operons" can" be"
predicted"with"confidence"using"bioinformatics."In"this"study"the"Database"for"prOkaryotic"
OpeRons" (DOOR)" (Mao" et" al.," 2009," 2014)" was" used" to" identify" potentially" interesting"

















the" ones" in" italic' bold" have" been" structurally" characterized" in" this" study." Structural"















PA1621" 270" Probable"hydrolase" Cytoplasm( 18" "
PA1622* 286" Probable"hydrolase" Cytoplasm( 18" "
PA1623* 220" Hypothetical"protein" Cytoplasm( 25" pdb:"1ECJ"
PA1624* 268" Hypothetical"protein" unknown( 9" "
3793'
bp'
PA3904( 131( hypothetical(protein( unknown( 10" "PA3905( 175( hypothetical(protein( unknown( 35" "PA3906( 127( hypothetical(protein( Cytoplasm( 40" "PA3907( 261( hypothetical(protein( Cytoplasm( 0" "PA3908( 239( hypothetical(protein( Cytoplasm( 0" "
1958'
bp'
PA4642( 96( hypothetical(protein( Cytoplasm( 15" "PA4643( 161( hypothetical(protein( unknown( 29" "PA4644( 157( hypothetical(protein( unknown( 17" "PA4645( 185( hypoxanthine[guanine(phosphoribosyltransferase( Cytoplasm( 28" "
3579'
bp'
PA5506* 285" hypothetical"protein" Cytoplasm( 16" "
PA5507* 217" hypothetical"protein" Cytoplasm( 21" "
PA5508* 443" hypothetical"protein" Cytoplasm( 23" pdb:"4HPP"
(Ladner"et"






described"elsewhere" (Hoang"et" al.," 1998;"Qiu"et" al.," 2008)."Mutants"were"generated"by"
48"
"
the" excision" of" the" target" operon" from" the" genome" using" a" recombination"method." In"
detail,"two"fragments"of"about"500"base"pairs"flanking"the"end"of"the"desired"operon"to"
knock"out"on"either"side"were"amplified"from"genomic"DNA"of"Pseudomonas*aeruginosa*






Prepare&PCR&mix&(25&µl):&100(ng(5’[shoulder(100(ng(3’[shoulder(100(ng(Gmres((200(µM(dNTP(mix((1(x(KOD(reaction(buffer((5x)(0.5( µl( KOD( polymerase((1U/µl)(1(mM(MgSO4((3%(DMSO(final(concentration(Add(PCR[grade(water(to(25(µl&
(on(ice(( (














The" generated" fragments" were" inserted" into" linearized" plasmid" pEX18Tc" at" the" SmaI*
restriction"site."Its"nonUPseudomonas"origin"of"replication"drives"genomic"integration."The"
plasmid"also"contains"the"sacB*gene"from"Bacillus*subtilis"which"encodes"for"exoenzyme"
levansucrase" (Gay"et"al.," 1983)"providing"a"marker" for"negative" counterselection"during"







Table'18:'Example'of'3‘8'and'5‘8shoulders'generated'and'used'in'overlap'PCR'with'gentamycin'cassette''PCR(fragment( 1621m1_2( 1624m3_4( Gmr( 1621m1_2(+(Gmr( 1624m3_4(+(Gmr(Size((bp)( 680( 599( 1057( 1720( 1639(
"
The"furnished"plasmid"was"transformed"into"electroUcompetent"Pseudomonas*aeruginosa*












Pseudomonas*aeruginosa"mutants"were"grown" in"60"ml"MillerUHinton" II"media" at" 37°C,"
shaking"at"140"rpm."The"broth"was" inoculated"with"a"single"colony,"picked" from"double"






before" weighting" them" (vial" weight)." After" three" hours," 10" ml" of" culture" volume" was"
collected," its" optical" density" noted" (ideal" was" 2.0)" and" cell" harvested" in" a" preUcooled"


































In" biochemical" science" knowledge" about" a" spatial" macromolecular" structure" is" of"
importance" to" understand" the" function" of" a" protein" on" the" molecular" level." ProteinU
protein"complex"structures"have"been"determined"by"cryo"electron"microscopy"(CryoUEM)"
to" moderate" resolution" (Vinothkumar" et" al.," 2014)" and" nuclear" magnetic" resonance"








Resolution" (!)" is" the" capacity" of" an" optical" system" to" resolve" two" objects" as" separate"












400" –" 700" nm)" (Goodwin," 2014)." This" does" not" match" the" requirements" to" enlighten"
atomic"details"of"a"protein"structure"by"orders"of"magnitude."Assuming"two"carbon"atoms"





defined" crystal" lattice" utilizing" the" concept" of" constructive" inference." " Scattering"
information" generated" by" every" molecule" arranged" in" the" crystal" contributes" to"




Protein" crystals" contain" on" average" 50%" solvent," which" renders" them" rather" fragile"
compared"to"a"salt"crystal"(Matthews,"1968;"Chruszcz"et"al.,"2008)."As"a"consequence"and"
in"contrast,"macromolecular"crystals"need"to"be"grown"from"aqueous"solution,"explaining"
their" fragility" and" disintegration" upon" dehydration" and" sensitivity" to" all" kinds" of"
environmental"variations.""
The"physical"background"of"crystal"formation"is"not"yet"fully"understood"(Haas"&"Drenth,"
1999)." Considering" a" phase" diagram" (figure" 14)" with" a"metastable" immiscibility" region,"
crystallization" of" proteins" from" a" solution" follows" a" distinct" twoUstep" process"with" two"
inseparable" steps:" nucleation" and" crystal" growth." The" process" involves" a" transition" at"
which"protein"molecules"are"present"in"a"concentration"higher"than"their"solubility"level."
Stabilized" by" the" physical" and" chemical" environment" of" the" mother" liquor"
macromolecules" in" these"metastable" liquid"droplets"allocate" from" fully"disorder" into"an"
ordered"state"in"paraUcrystalline"nuclei"(McPherson"et"al.,"2000)."With"the"momentum"of"
the" reestablishment"of" the"protein"equilibrium"nuclei" spread"out"and"become" larger"by"
the"attachment"of"molecules" in"all"dimensions," leading" to" threeUdimensional"nucleation"










e.g." temperature," salt" concentration," addition" of" polymers" and/or" precipitant"
concentration," in"practice,"many"parameters"are" tuned" in"a"controlled"way"at" the"same"
time." Initial" crystallization" conditions" are" mostly" searched" with" commercial" screening"
suites." Once" drops" containing" undersaturated" protein" solution" and" premixed" mother"
liquor"are"set"up"the"compartment" is" tightly"sealed."The"restricted"correspondence"only"
between"the"small"protein"containing"drop"and"the"mother"liquor"reservoir"attracts"water"
molecules" by" the" slightly" higher" concentration" of" precipitant" to" the" reservoir," thereby"
elevating" the" protein" concentration" towards" supersaturation." Added" Polymers" induce"
molecular" crowding" by" the" volumeUexclusion" effect" that" induces" separation" of" solution"
and" protein" molecules" (Ingham," 1984," 1990;" Englard" &" Seifter," 1990)." Systematic"
optimization"of"hit"conditions"was"carried"out"until"desired"crystals"are"isolated"and"cryoU
protected"to"minimize"radiation"damage"and"extend"the" life" time"of" the"crystal"prior" to"
exposer"to"an"xUray"beam"at"100"Kelvin."
A"diffraction"pattern"generated"by"a"protein"crystal" is" shown" in" figure"15." Its"diffraction"
limit" can"be"correlated"with" its"degree"of" internal"order," called"mosaicity."Theoretically,"
the" more" uniform" molecules" are" arranged" with" the" protein" lattice," the" higher" is" the"






to" diffraction," moreover" they" limit" theoretical" resolution" due" to" “diffuse" scattering”""
(Shpyrko"et"al.,"2004;"Xu"et"al.,"2012).""
"















beam." Because" of" experimental" setup" rays" are" of" discrete" wavelength" and" in" parallel"
phase"when"striking"the"different"layers"of"the"protein"crystal."Coherent"incident"photons"






Right" triangle" !"#" extracted" from" figure" 17" recognizes" !" as" hypotenuse." Using"
trigonometry"were"sin! = !" !"results"in""




!" = 2! sin ! !!!!!!!!!!(4)"
Equation:'Bragg’s'Law,'explaining'crystals'reflect'an'X8ray'beam'at'certain'angles'and'manner.'The'variable'lamba'!'is'
the'wavelength' of' an' x8ray' beam;'!' is' the' distance' between' lattice' layers' in' the' crystal' lattice' and'!' an' integer'
number.'























determined" at" distance" 1/dhkl" form" the" origin" where" dhkl" is" the" perpendicular" distance"










the" direct" unit" cell" lattice." Assuming" α" =" β" =" γ" =" 90°" the" reciprocal" unit" cell" vectors"!∗ , !∗ , !∗ 'can"be"calculated"as"given"as"





The" Ewald" construction" represents" a" crystal" by" its" reciprocal" lattice" points." The" Ewald"
sphere"is"a"threeUdimensional"construction"with"the"radius!1 !."Reciprocal" lattice"points"
which" coincide" with" the" Ewald" sphere" are" satisfying" Bragg’s" law" and" are" therefore"
contributing"to"constructive"interference"of"the"scattered"beam."For"a"random"orientated"
crystal" that" is" rotated" during" an" experiment," the" reciprocal" lattice" will" rotate" as" well"
(figure"21)."Reciprocal"lattice"points"get"in"contact"with"the"constructed"Ewald"sphere"and"
diffraction" will" occurs." Figure" 21" illustrates" this" for" the" case" where" h,k,l"="2,0,0." The"









all" x," y" and" z" in" the" unit" cell." During" data" collection" diffraction" images" are" recorded"
including" information" about" the" position" (hkl)" and" the" intensity" (Ihkl)" of" each" reflection"
within"a"diffraction"pattern."The"structure"factors"can"be"calculated"if"the"content"of"the"
unit" cell" in" known." Thus," crystallographic" experiments" deal" with" the" inverse" problem."
Information" regarding" the"structure" factors" is"available"but" the"content"of" the"crystal" is"
unknown." If" the" structure" factor" equation" is" applied" to" a" Fourier" transformation" the"
equation" describing" the" electron" density" in" the" crystal" is" yielded." The" Fourier"
transformation"of" the"diffraction"data" is" the" representation"of" the" crystals" content," the"

























more" complex" molecules" (figure" 23)" are" arranged" in" a" grid" (figure" 24)." The" resulting"








During"data" collection" acquired" images" contain" reflections"of" an" xUray"beam"which"was"
diffracted"on"the"electron"envelope"of"a"protein"arranged"in"the"unit"cell."In"principle"the"
electron" distribution" in" the" crystal" is" depicted" within" the" images," however," a" direct"
interpretation" and" reconstitution" is" not" possible" because" the" collected" data" does" only"
contain" geometric" position" (index" ℎ!")" and" attributed" intensities" (!!!")" for" each"
reflection." The" diffraction" pattern" is" related" to" the" object" scattering" them." The"
mathematical"operation"needed" to" convert" the"pattern" in"a" three"dimensional" electron"
density" is" called" Fourier" transformation." If" the" electron" density" is" the" mathematical"
function,"then"the"diffraction"pattern"is"the"Fourier"transform"of"that"function."A"Fourier"
transformation" in" either" direction" requires" structure" factors" consisting" of" two" things:"
amplitude"and"phase."During"data"collection"the"information"containing"the"phase"is"lost,"
which" results" in" the"phase"problem."Since" there" is"no"practical"way" to"measure" relative"
phase" angles" for" the" different" reflections" experimentally," the" only" parameter" that" is"
measured"amplitudes"and"the"intensity"of"each"spot"on"the"detector"called"|Fobs|."
The"structure"factor"!! ℎ!" "includes"the"length"of"the"vector"but"also"the"phase"!(ℎ!")."
!! ℎ!" = !! ℎ!" ∙ !!!! !!" "
The" electron" density" is" calculated" by" a" Fourier" transformation" of" all" structure" factors""!! ℎ!" ."
62"
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As" described" previously" the" phase" problem" can" be" solved" by" either" molecular"
replacement,"which" is" restricted"by" the"existence"of" a" similar"protein" structure"used"as"
search"model"or"experimental"phasing"by"anomalous"diffraction.""
Molecular" replacement" uses" the"phase" from"an" existing"model" structure" and" combines"
this"with"the"experimentally"measured"amplitudes"of"a"target"protein"structure,"depicted"
in"figure"27."In"practice"this"method,"however,"can"only"be"employed"if"the"target"protein"


















Incident" photons" will" scatter" in" case" of" insufficient" energy" responsible" for" causing" a"
transition"of"an"electron."However,"if"incident"xUrays"approach"or"match"the"energy"of"an"
element," electronic" transition" occurs" and" xUrays" are" absorbed" and" only" part" of" the"

















as"followed:"!!"# = !!° ! + !∆ ! = !° ! + !∆ ! !!" = !° ! + !! ! + !!!! ! "
The"!°"parameter" is"purely"real"and"independent"of"wavelength."The"scattered"intensity"
falls"off"with"increasing"scattering"angle"(θ)"due"to"diffuseness"of"the"outer"electron"shells"
of"the"scattering"atoms"(Hendrickson,"1991)."The"second"!∆ ! " is"complex"with"the"real"!! ! " and" the" imaginary" part" !!!! ! ." In" contrast" to!!°," !∆" is" depended" on" a" discrete"
wavelength"but"virtually"independent"of"scattering"angle."The"parameters"(!!"and"!!!)"are"
directly"determined"from"an"adsorption"–"fluorescence"scan"prior"to"accurate"anomalous"





Friedel’s"law"they"have"equal"amplitude"but"opposite"phase."|!!!"| = !!!" = !!!!!!! !!!!! "#ℎ!!!!! !!" = −!!!" = −!!!!!!! "
The"diffraction"pattern"of"a"crystal"is"centroUsymmetrical"which"relates"pairs"of"the"same"




match"anymore"so"that"|!!!"| ≠ !!!" "and"!!!" ≠ −!!!" "as"well"as"|!!| ≠ |!!|"resulting"









2012)" for" initial" refinement." The"output"model"was"used"as" starting"model" for" iterative"
rounds"of"manual"adjustments"by"COOT"and"further"phase"improvements"and"refinement"









Determined" phases" may" contain" errors" which" are" reflected" in" errors" in" the" electron"
density" ρ(x!y!z)." These" errors" are" corrected" by" structure" refinement," both" by" manual"




out" in" reciprocal" space." First," structure" factors" of" a" model" are" calculated" by" Fourier"
transformation," |!!|." Second," the" experimentally" determined" structure" factors" are"
compared" to"model"one"by"using" sophisticated"algorithms" (McCoy,"2002;"McCoy"et" al.,"
2004;"Pannu"&"Read,"2004)"which"are"trying"to"minimize"the"difference"between"both"by"










Table19:'Datasets'used'for'structure'determination'Project( Dataset(( λ(Å)( Space(group( Software(PA1622( SeMet_pk& 0.9760( P61( SHELX(PA1623( SeMet_pk& ( P21212( Phenix.AutoSol(PA1624( SeMet_pk& 0.9800( P212121( Phenix.AutoSol(PA5506( SeMet_ip& 0.97992( P212121( SHELX(/(Phenix.AutoSol(














nanodispensing" robot" (Phenix," Art" Robbins" Instruments" or" HoneyBee," Digilab" Genomic"
Solutions)"on"an"MRC3Udrop"plate"(Molecular"Dimensions)"or"Intelli"Plate"(Art"Robinson)."
All" crystallization" trails" were" incubated" at" 20°C" in" a" temperature" controlled" imaging"
system"(Formulatrix)."Initial"crystals"hits"were"further"optimized"in"size"and"shape"during"
several" rounds"of" grid" screening"optimization"with" 1"µl" protein" plus" 1"µl"mother" liquor"








with" a" MAR345" image" plate" detector" or" a" Rigaku" MicroMaxU007" HF" generator" with" a"
Rigaku" Saturn" 944+" CCD" detector;" both" systems" were" equipped" with" an" OxfordCryo"































Phases" can"either"be"obtained"by"molecular" replacement"with"e.g."BALBES" (Long"et" al.,"
2008)." In"other"cases"the"phases"need"to"be"determined"from"either"multi"MAD"or"SAD"




positions" (SHELXD)" served" as" an" additional" input" file" for" AutoSol" (Zwart" et" al.," 2008)"
implementing" Xtriage" for" data" quality" analysis," PHASER" (McCoy" et" al.," 2007)" for"
calculation"of"the"experimental"phases."RESOLVE"(Terwilliger,"2000)"was"used"for"density"





















The"nonUessential"protein"PA1622" is"a"31.1"kDa"gene"product"of"unknown"function." It" is"
predicted"to"be"localized"in"the"cytosol"of"Pseudomonas"aeruginosa*PAO1"(Petersen"et"al.,"
2011)." Its"sequence"was"taken"from"the"Pseudomonas"Genome"Database"(PGD)"(Winsor"
et" al.," 2011)" and" analyzed" by" a" Blast" search" revealing" 47" orthologs" in" Pseudomonas*
species." Automated" annotation" based" on" the" presence" of" conserved" amino" acids"
sequences" and" structural" features" indicated" that" the" protein" belongs" to" the" class" of"
hydrolases" (EC"3.1.1.XX)." This" annotation"was" confirmed"by"a" reversed"position" specific"
blast" (RPSBLAST)" screening" for" cluster" of" orthologous" groups" (COGs)" as"member" of" the"
alpha/beta"hydrolase"superfamily."Its"possible"function"was"predicted"as"an"atropine"acylU
transferase"based"on"35%"sequence"identity"with"the"NUterminal"part"(residues"2U125)"of"
an" enzyme" from" Pseudomonas* putida," annotated" by" the" Pseudomonas* aeruginosa"
Community" Annotation" Project," PseudoCAP" (http://www.cmdr.ubc.ca/bobh/paap.html)"
(Winsor"et"al.,"2005)."
Sequence"domain" search"predicted" the" residues"25" through"about"125" to" fold" into"one"
domain"with"an"association"to"the"esterase"or"lipase"function"acting"on"carboxylic"esters"





alpha/beta"hydrolases" involving" serine" chemistry," the" classes"of" pUnitrobenzyl" esterases"




from" several" organisms" like"Pseudomonas* aeruginosa" and"Rhodopseudomonas" but" also"
Burkholderia,* Thermus* spec* and* Bacillus* subtilis" were" identified." The" results" are"




activity," from" Xanthomonas" (Medrano" et" al.," 1997)" and" Thermus* species" (Okai" et" al.,"
2007),"highlighted"in"bold"and"marked"with"asterisk"in"table"21.""
Table'21:'Results'from'BLAST'search'against'the'Protein'Data'Bank'(Altschul'et'al.,'2005).''Protein(( Origin( Sequence(identity((%)( Query(coverage((%)( E[value( Pdb(code(
Thioesterase&Domain&*& Lyngbya*majuscula* 28& 86& 3EJ23& 3QIT&Alpha/Beta(hydrolase(( Nostoc&sp&PCC7120& 35( 34( 2E[09( 3QYJ(Epoxide(hydrolase( Pseudomonas&
aeruginosa&PAO1&
37( 34( 8E[09( 4BAU(Fluoroacetate(dehalogenase( Rhodopseudomonas&
palustris&
35( 37( 3E[08( 3R3V(Acyltransferase( Salmonella&enterica& 33( 34( 6E[08( 4NVR(E[2[(Acetamidomethylene)(succinate(hydrolase( Mesorhizobium&loti& 31( 57( 1E[07( 3KXP(Aryl(esterase( Burkholderia&
cenocepacia&
32( 40( 2E[07( 4X00(Chloroperoxidase(L( Streptomyces&lividans& 33( 42( 9E[07( 1A88(
Proline&iminopeptidase&*& Xanthomonas*
campestris*
32& 35& 2EJ06& 1AZW&Epoxide(hydrolase(B( Mycobacterium&
tuberculosis&
32( 38( 2E[06( 2E3J(Bromoperoxidase(A2( Streptomyces&
aureofaciens&
26( 63( 4E[06( 1BRO(Hsad( Mycobacterium&
tuberculosis&
32( 41( 5E[06( 2VF2(Chloroperoxidase(T( Streptomyces&
aureofaciens&
30( 39( 1E[05( 1A7U(
Proline&iminopeptidase&*& Thermus*
thermophilus*











Besides" this," 19" similar"models"have"been"generated"based"on"different"PDB" templates"
(table"21)."All"20"structures"are"shown"in"its"superposition"in"figure"36."""
"






reported'by'Phyre'(Kelley'&'Sternberg,'2009).'Epoxide'hydrolases'are'marked'in'bold'and'transferases'in'italic.''TM[score(*(( Ranking( PDB(id(((figure(3)( (potential)(function( PDB(header(
1.00& 1( 1cr6(((Chain('A')( soluble(epoxide(hydrolase( Hydrolase((
0.97& 2( 3i28(((Chain('B')( soluble(epoxide(hydrolase( Hydrolase((
0.78& 13( 3kda(((Chain('C')( epoxide(hydrolase((( Hydrolase((
0.77& 19( 4inz(((Chain('D')( epoxide(hydrolase(( Hydrolase((
0.75& 18( 4b9a(((Chain('E')( putative(epoxide(hydrolase( Hydrolase((0.74( 17( 3wib(((Chain('F')( haloalkane(dehalogenase((( Hydrolase((
0.73& 15( 2e3j(((Chain('G')( epoxide(hydrolase((ephb)(( Hydrolase((0.72( 20( 1c4x(((Chain('H')( Carbon[carbon(bond(hydrolase( Hydrolase((0.72( 12( 4opm(((Chain('I')( putative(lipase((lip1)(( Hydrolase((0.71( 16( 1b6g(((Chain('J')( haloalkane(dehalogenase( Dehalogenase((0.70( 8( 3oos(((Chain('K')( alpha/beta(hydrolase(( Hydrolase((0.69( 10( 2r11(((Chain('L')( putative(hydrolase((2632844)( Hydrolase((0.68( 9((( *((3qit(((Chain('M')( thioesterase(domain(( Hydrolase((0.67( 5( 4d9j(((Chain('N')( designed(tetrahedral(protein(cage(( de(novo(protein((0.65( 11( 4ose(((Chain('O')( putative(hydrolase(( Hydrolase((0.63( 14( 2b61(((Chain('P')( O[acetyltransferase( Transferase((0.62( 3( 1azw(((Chain('Q')( proline(iminopeptidase[like( hydrolase(((0.62( 7( 2vav(((Chain('R')( acetyltransferase(( Transferase((0.61( 6( d1wm(((Chain('S')( Proline(iminopeptidase[like( hydrolase(((0.61( 4( 4qlo(((Chain('T')( homoserine(o[acetyltransferase(( Transferase((
"
The" results" are" ranked" according" to" their" TMUscore," which" represents" the" structural"
overall" similarity." Interestingly," six" out" of" the" seven"best"models" are" based"on"proteins"
with"an"epoxide"hydrolase" function," followed"by"hydrolases"with" lipaseU,"haloalkaneU"or"
unknown" function."Proteins"with" transferase"and"peptidase"activity" complete" the" table."
Although" the" structures" share" the" same" overall" fold," differences" can" be" identified" and"
78"
"
some" of" the" structures" categorized" in" protein" subUfolds" (figure" 37)." The" thioesterase"
domain"(asterisk"in"table"22)"shows"a"different"fold"(colored"grey"U"figure"36A"and"37C)"as"
well" as" the" transferase" based" models" (rank" 4," 7" and" 14," table" 22)" and" the" proline"








group" P61" with" almost" identical" cell" dimensions" (table" 2)." Final" buffer" conditions" are"
summarized"in"table"3"and"4."The"content"of"the"asymmetric"unit"was"calculated"for"four"
to" six"monomers"with"a"Matthews" coefficient"of" 3.16," 2.52"and"2.1" reflecting"a" solvent"
content" of" 61%," 51%" or" 41%," respectively." The" 286" amino" acid" protein" features" 7"
methionine"residues"within"a"single"protein"chain."The"structure"was"solved"using"SeMet"
SAD" phasing" followed" by" phase" extension"with" native" data" to" higher" resolution." SHELX"
(Sheldrick,"2010)"located"the"heavy"atom"sites"and"the"phenix"application"AutoSol"(Zwart"
et" al.," 2008)" was" used" to" solve" the" structure" including" initial" model" building." Visual"
inspection" indicated" the" presence" of" four" protein" molecules" in" the" asymmetric" unit"








A' top' shows' the' six' fold' symmetry' (A)' and'a' side' view' (B).' The' tetramer' is' always' shown' in' identical' orientation'
aside.''
"



































The" polypeptide" chain" of" each" monomer" was" visible" and" ordered" to" the" CUterminus."
Manual" adjustments" and" improvements" of" the" initial" model" were" done" using" COOT"


















































overall"morphology."The" core" (residues"1U127"and"215U286" (colored" in" light"blue," figure"
41B)"is"built"by"an"arrangement"of"8"mostly"parallel"beta"sheets"while"β2"is"the"only"one"
running"antiparallel."The"blade"of"sheets"is"tightly"twisted"by"about"120°"from"the"first"(β1)"
to" the" last" one" (β10)" finishing" the" organization" close" to" the" CUterminus." It" is" flanked" by"
alpha"helices"α1"and"α9"on"one"side"while"alpha"helix"2,"3"and"8"packs"on"the"other"side"of"
the" large"beta" sheet."A" smaller"domain" is" inserted"between"amino"acid"128"and"214." It"
comprises"four"alpha"helices"and"one"small"anti"parallel"beta"sheet"(figure"41B,"colored"in"
light" yellow)" sitting"on" top"of" the" compact" coreUdomain" like"a" covering" lid" collected"via"
linker"regions"stained"in"green"(figure"41AUC).""
"
Figure' 41:' Structure' of' the' PA1622'monomer' showing' the' two' domains' colored' in' yellow' and' light' blue' (B).' The'
















contact" to" the" backbone" carbonyl" of" leucine" 185," both" contributing" to" the" stability."
Additionally,"the"lid"domain"is"participating"in"dimer"interaction."
This" protein" fold" leads" to" 88%" of" all" protein" residues" exposed" to" the" surface" with" a"
calculated"total"area"of"about"13800"A²"per"monomer"(Krissinel"&"Henrick,"2007)."Domain"
analysis" indicates" that" a" dimer" of" two" chains" and" the" tetrameric" assembly" are" possible"
assemblies"that"are"favored"over"the"monomeric"state"(table"27).""
Table'27:'Analysis'results'of'the'PA1622'protein'tetrameric'complex'using'PISA'(Krissinel'&'Henrick,'2007)'Composition(( stable( Surface(area(((sq.(Å)( Buried(area((((sq.(Å)(( ΔGint((((kcal/mol)( ΔGdiss(((kcal/mol)(
ABCD& yes( 42290( 11230(( [78.4( 0.4(
AB& yes( 23540( 3320(( [35.7( 22.8(
CD& yes( 23320( 3340(( [34.3( 21.6(
A& Yes( 13836( [[( [[( [[(
"
The" solvent" accessible" surface" is" reduced"by" about" 15%"upon"protein" dimerization" and"
further" reduced" by" assembly" of" the" tetramer" with" 27%" of" the" total" accessible" surface"
buried."The"gain"in"solvation"free"energy"was"calculated"to"U35"kcal/mol"and"U78"kcal/mol,"
respectivey."The"dimer"interface"between"chain"A"U"B"or"C"–"D,"generated"by"alpha"helix"2U
4" and" 7" as" well" as" the" loop" regions" connecting" β4" and" α2" and" β8" with" α7," is" mostly"
hydrophobic"with"a"calculated" interface"area"of"1670"Å²."The"second" interface"between"
the" two" dimers" (figure" 42C)" is" rather" hydrophilic" with" a" calculated" size" of" 1330" Å²."
Generated" by" alpha" helix" 2," 5" and" 6" it" also" involves" beta" sheet" 1," 2" and" the" betaUturn"
(β7β8)" patching" to" the"other"monomer’s"beta"blade," extending" it" to" a"10" stranded"beta"
sheet." Furthermore" the" NUterminus" grabs" the" other" monomer" in" a" finger" like" manner"
(figure" 8C)." The" dominating" interactions" here" are" eight" salt" bridgeU" and" five" hydrogen"
bonds"across"the"interface."The"PUvalue"for"the"calculated"solvation"free"energy"gain"(U5.3"
kcal/mol)" with" 0.9" is" rather" large," indicating" that" this" interface"might" be" an" artifact" of"
crystal"packing"(Krissinel"&"Henrick,"2007;"Krissinel,"2010)."This"is"supported"by"a"low"CSS"
value"of"0.2."Both"interfaces"do"contribute"to"the"proteins"stability"as"calculated"by"PISA"




Table' 28:' Results' of' DLS' experiment' using' PA1622;' The' translational' diffusion' coefficient' ='D,' the' hydrodynamic'
radius' (R)'with'the'corresponding'diameter,'Dia.'The'polydispersity' (Pd)' is'calculated'to'a'percentage'value.'Molar'
mass'(MW;R)'is'estimated'upon'particle'conformation,'size'and'solution'density.'All'calculation'were'done'based'on'
a'classical'spherical'fitting'model'(Nobbmann'et'al.,'2007).'Temperature((°C)( Peak((#)( D((cm²/s)( R((nm)( Dia((nm)( Pd(((%)( MW[R((kDa)( Int((%)( Mass((%)(
20& 1( 5.76E[07( 3.6( 7.3( 9.4( 69.0& 98.81( 99.9994&
& 2( 1.72E[08( 122.1( 244.3( 15.5( 2571.0& 1.19( 0.0006(
15& 1( 5.72E[07( 3.7( 7.3( 10.4( 70.7& 100( 100&
10& 1( 4.40E[07( 3.5( 7.0( 5.9( 63.7& 100( 100&
"
Data"revealed"a"molecular"particle"weight"of"approximately"65"kDa"with"a"diameter"of"73"
Å." The"diameter"of" a"protein" in" the" crystal" structure"dimer" (62" kDa)" and" tetramer" (248"
kDa)"were"measured" to" approximately" 75" Å" and" 90" Å," respectively." The" low" degree" of"
polydispersity" and" a" mass" accuracy" of" 100%" indicate" a" homogenous" monodisperse"
solution." In" summary," the" tetramer" is"most" likely" a" crystallization" artifact" rather" than" a"
natural" stable" structure" (table" 8)," which" is" also" in" congruence" with" results" from" gel"
filtration"where"PA1622"eluted"as"a"dimer.""
"





Dimer" protein" interface"was" used" as" subject" searching" for" similar" interfaces"within" the"
PDB"archive"(Berman"et"al.,"2000),"one"similar"dimer"assembly"is"revealed,"a"thioesterase"






Superposition" of" PA1622" with" all" predicted" models" by" Phyre" (figure" 9A)" revealed" one"
structure" of" significant" similarity." The"model" previously" named" as" ‘outlier" protein" fold’"





The" thioesterase" domain" monomer" superimposes" with" an" r.m.s.d." of" 1.9" Å" and" the"
protein" dimer" with" 2.3" Å" to" PA1622" (figure" 44A" and" B)." The" hydrophobic" protein"
dimerization" interface"has"significant"similarity"to"the"one" in"PA1622."Further"significant"











proteins" of" similar" fold." An" alignment" of" 1000" nonUredundant" protein" sequences" of"
members"of"the"alpha/beta"hydrolase"superfamily"revealed"a"conservation"of"the"catalytic"
histidine"with"either"a"serine"or"an"aspartic"acid"as"active"site"nucleophile."The"position"of"












within" a" signature" sequence" Gly100UHis101USer102UX103(M)UGly104" (figure" 45)" in" the"
constrained" geometric" nucleophilic" elbow" which" is" a" hallmark" of" alpha/beta" hydrolase"
proteins."It"is"located"at"the"NUterminus"of"an"alpha"helix"(α3)"which"supports"the"stability"
of" the" deprotonated" state" during" catalysis" by" helical" dipole" stabilization." The" histidine"
residue"(His263)"and"the"aspartic"acid"residues"(Asp126)"are"both"located"on"loop"regions"
connecting"β10" to"α9"and"β6" to" the"protruding"helix,"α4."Particularly," the"histidine"of" the"
signature" sequence" (His101)"makes" a" hydrogen" bond" to" the" backbone" carbonyl" of" the"
active" site" histidine," stabilizing" the" alignment" of" the" triad" in" close" proximity" with" a"








The" largest" part" of" the" active" site" pocket" in" PA1622" is" lined" with" aliphatic" residues"
including" Ile106," Trp36," Leu77," Trp78," Met103," Pro130," Leu212," rendering" the" largest"
portion" hydrophobic" except" for" 3" polar" residues" lining" the" other" side" of" Ser102." An"
aspartate" (Asp38)"and" two"histidine" residues" (His101"and"His264)"are" located" in" closest"
proximity"to"the"catalytic"triad."The"amide"backbone"atoms"of"methionine"(Met101)"and"
tryptophan"(Trp36)"generate"an"oxiUanion"hole"to"compensate"distributed"charges"of"an"
intermediate" state" during" catalysis." In" fact," while" refining" the" protein" structure," extra"
electron" density" which" could" not" be" interpreted" by" the" polypeptide" chain" could" be"
observed." This" density" is" rising" from" the" active" site," covalently" modifying" the" serine"
residue"and"branches"out" in"the"active"site"pocket."However,"the"molecule"could"not"be"
full" interpreted" due" inconsistencies" in" electron" density." The" ligand" molecule" possibly"


























et" al.," 2014)." In" the" open," inactive" conformation" the" residues" assembling" the" catalytic"
triad" are" distant" from" each" other" with" a" widely" opened" active" site" pocket." A" global"
conformational" change" involving" a" reorientation" of" the" lid" domain" causes" a" drastic"
shrinkage"of"the"active"site"pocket,"bringing"the"catalytic"into"close"proximity.""
This"however,"does"not"apply" to"PA1622,"because" its"dimeric"organization"PA1622" fixes"
the"lidUdomain"in"an"open"position"that"does"not"allow"a"lid"movement"in"the"same"way"as"
described" for" a" similar"Pseudomonas* aeruginosa" protein"with" lipase" activity" (Nardini" et"
91"
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##" QUscore" PUscore" ZUscore" RMSD"(Å)" Nalgn" Nucleophile" SeqUid"(%)" PDB"ID"
1" 0,55" 14,46" 11,88" 2,12" 249" Ser106" 0,27" 3QIT'
2" 0,54" 19,29" 13,87" 1,71" 233" Ser106" 0,23" 3KXP"
3" 0,41" 8,421" 10,12" 2,38" 233" Ser104" 0,22" 3BWX"
4" 0,39" 10,45" 10,6" 2,35" 225" Ser154" 0,2" 3P2M"
5" 0,38" 8,154" 9,94" 2,22" 221" Ser156" 0,28" 3C5W"
"
The" two" structures" ranked" 4" and" 5" can" be" grouped" into" one" subUclass" with" slightly"
different" fold" (Xing"et"al.,"2008;"Zheng"et"al.,"2011)."Structures"ranked"second"and"third"
possess"an"NUterminal"extension"and"an"altered"fold"compared"to"PA1622"(McCulloch"et"
al.," 2010)." The" result" ranked" best" is" the" previously" discussed" protein" domain" with"






Results" from"a"DALI" search" (Holm"&"Rosenström,"2010)" (table"30)" analyzed"by"multiple"
sequence" and" structure" alignment" revealed" an" insertion" of" 22" amino" acids" into" the"
primary"sequence"of"PA1622"and"3QIT"(figure"49)."
Table'30:'Protein'structures'identified'as'structural'homologous'through'a'DALI'search.'The'best8ranked'15'are'listed.'
PDB"ID" ZUScore" RMSD"(Å)" Seq"Id"(%)" Protein"function"(as"known)"
3qit""" 29,2" 2,4" 27" Polyketide"synthase"thioesterase""
3kxp""" 29,1" 2,5" 22" αU(NUAcetylaminomethylene)succinate"hydrolase"
4ose""" 26,6" 2,5" 18" Putative"hydrolase"
3bwx""" 25,4" 3" 22" Alpha/beta"hydrolase"
3c5v""" 25,3" 2,9" 26" Phosphatase"methyltransferase"1"""
1j1i""" 25,2" 2,6" 17" Meta"cleavage"compound"hydrolase"
3qyj""" 24,7" 3" 22" Putative"Alpha/beta"hydrolase"
1y37""" 24,5" 3" 22" Fluoroacetate"dehalogenase""
4opm""" 24,5" 2,3" 16" Putative"lipase""
3r3u""" 24,3" 2,8" 20" Fluoroacetate"dehalogenase"
1ehy""" 24,3" 3,1" 18" Soluble"epoxide"hydrolase"
4ns4""" 24,2" 2,5" 19" Alpha/beta"hydrolase"fold"protein""
4nvr""" 24,1" 3" 18" Putative"acyltranferase""
2xua" 24" 2,5" 16" 3Uoxoadiapate"enolUlactonase"







This" leads" to" a" substantially" longer" lid" domain" with" the" exclusive" formation" of" the"
protruding" helix," which" renders" the" fold" of" both" unique." Involved" in" key" interactions"
within" the"dimeric" structure" this"helix" is"essentially" responsible," supported"by"a" specific"
anchoring"arginine"(Arg186),"for"locking"the"lid"in"a"permanent"open"form"conformation."
Stabilizing"contacts"of"the"core"domain"with"the"lid"of"the"other"subunit"locks"its"position"








The" protein" sequence" of" PA1623"was" taken" from" the" Pseudomonas"Genome"Database"







(Wilkins" et" al.," 1999)." A" BLAST" search" (Altschul" et" al.," 1997)" indicated" a" conservation"
among" Pseudomonas* species" with" 32" putative" orthologs," which" is" in" agreement" to"
automated"annotation"in"the"PGD,"classifying"PA1623"as"‘conserved"hypothetical"protein’."











likely" belongs" to" the" cytosolic" glutathioneUSUtransferase" superfamily," indicated" by" a"

















99" 100" 1eU161" 4ECI"(*)"
GST" Burkholderia*graminis* 52" 91" 2eU63" 4MF5"
GST" Xenorhabdus*
nematophila*
47" 88" 2eU61" 4L8E"
GST" Bradyrhizobium*sp* 50" 91" 9eU59" 4MF7"
GST" Pseudomonas*
fluorescens*PfK5*
47" 91" 8eU57" 4IKH"
Oxidoreductase" Escherichia*coli*KK12* 46" 95" 7eU56" 3GX0"
GST" Pseudomonas*putida* 47" 92" 4eU55" 4NAX"
GST" Phanerochaete*
chrysosporium*
46" 88" 8eU48" 4F0B"
GST" Streptococcus*sanguinis*
Sk36*
41" 91" 2eU41" 4MZW"




38" 92" 1eU37" 4PUA"
GST" Lodderomyces*
elongisporus*
35" 93" 5eU36" 4IVF"
GST" Saccharomyces*
cerevisiae*













function" is" detoxification" by" conjugation" of" electrophilic" endogenous" or" xenobiotic"
compounds" to" glutathione" rendering" them" less" toxic" and"more" polar." Apart" from" this,"
multifunctional" cytosolic"members"were" reported" that" are" involved" in" the" reduction" of"
oxidized" cellular" macromolecules," function" in" the" biosynthesis" of" metabolites" (Oakley,"
2005)" and" are" involved" in" signaling" pathways" (Laborde," 2010;" Davis" et" al.," 2011)." The"
dimeric" proteins" specifically" bind" the" tripeptide" glutathione" within" their" NUterminal"
domain."The"second"domain"comprises"a"rather"variable"amino"acid"pattern"rendering"it"





tartrate," 0.1"M" Bis/Tris" pH" 6.7" and" 18%" PEG" 3350" using" a" protein" concentration" of" 15"
mg/ml."Trials"using"molecular"replacement"with"protein"structures"available"in"early"2010"
failed."Hence,"the"structure"of"PA1623"was"solved"by"SAD"phasing,"using"the"anomalous"
signal" of" the"7" LUselenomethionine" residues" incorporated" in" the"polypeptide" chain." The"
labeled" protein" crystallized" in" space" group" P21212" with" 2"molecules" in" the" asymmetric"
unit." Heavy" atom" sites"were" located" by" SHELX" (Sheldrick," 2010)" and" used" as" additional"
input" file" to"AutoSol"used" for" structure" solution"and" initial"model"building" (Zwart"et"al.,"










Data"collection" PA1623"SeMet"α" PA1623"apo"ß" PA1623"U"GSSG"ß"
Detector" Pilatus"6M" Pilatus"6M" Pilatus"6M"
Wavelength"(Å)" 0.9779" 0.91841" 0.91841"
Resolution"range"(Å)" 48.7"–"2.0"(2.05"–"2.0)" 47"–"1.65"(1.68"–""1.65)" 45"–"1.30"(1.32"–"
1.30)"







Unique"reflections" 30352"(2233)" 52344"(2740)" 201735"(9969)"
Multiplicity" 6.4"(6.7)" 4.1"(4.1)" 4.3"(4.2)"
ano."Multiplicity" 3.2"(3.4)" UU" UU"
Mean"I/σ(I)" 15.1"(2.6)" 17.5"(2.5)" 10.7"(2.6)"
Completeness"(%)" 99.6"(95.1)" 99.8"(99.8)" 99.7"(100)"
ano."Completeness"(%)" 96.8"(93.1)" UU" UU"
Average"Mosaicity"°" 0.134" 0.201" 0.105"
Rmerge"(%)" 5.9"(55.3)" 6.8"(63.1)" 8.2"(54)""
Rmeas"(%)" 7"(65.5)" 7.8"(72.5)" 9.4"(61.8)"
Rpim"(%)" 3.2"(25.2)" 3.8"(35.3)" 4.4"(29.5)"
CC(1/2)"°" 0998"(0.932)" 0.999"(0.80)" 0.997"(0.792)"






Manual" model" adjustment" were" done" by" using" COOT" (Emsley" et" al.," 2010)" and"







































The" polypeptide" chain" of" PA1623" adopts" a" classical" canonical" glutathioneUSUtransferase"
(GST)"fold"(figure"52)."Two"identical"monomers,"which"are"rotated"by"180"degree,"form"a"
stable"protein"dimer." The" smaller"NUterminal"domain" (86" residues)" adopts" the" common"








The" characteristic" fold" consists" of" four" almost" planar" beta" sheets" surrounded" by" three"











2003)." The" proline" residue" (P53)" of" PA1623" is" shown" in" comparison" with" the" close"
homologues," table" 1,"PDB:" 4MF5" (Gerlt" et" al.," 2011)" and"PDB:" 3GX0" (Wadington" et" al.,"
2009)"(figure"54B).""
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the"GSH"binding"pocket." It" is" connected"via" a" short" linker" containing"of" six" amino"acids"
(80U86)"to"the"CUterminal"domain,"which"is"comprises"an"all"alpha"helical"fold"(residues"87U
220)."The"five"alpha"helices"wrap"around"each"other,"connected"by"short"loop"sequences."
The" domain" begins"with" a" long" alpha" helix,"which" crossUspans" the"whole" structure" and"
serves" as" major" contributor" to" the" protein" dimerization" interface." The" interactions"
between"the"protein"chains"are"mostly"hydrophobic."Furthermore"this"domain" is"mainly"
involved" in" recognition," interaction" as" well" as" binding" of" the" mostly" hydrophobic"
substrates." Its" diversity" in" composition" introduces" substrate" specificity" within" the" GST"
family" (Wilce" &" Parker," 1994)." A" phenylalanine" residue" (F66)" preceding" from" the" loop"
extending"β2"to"the"CUterminal"domain,"acts"as"a"key"residue"pointing"into"a"‘hydrophobic"




Figure' 55:' PA1623' comprises' two' domains,' the' N8terminal' thioredoxin8like' domain' and' alpha8helical' C8terminal'




202." The" last" eighteen"CUterminal" amino"acids" could"not"be" fit" due" the" lack"of" electron"
density."Furthermore,"during"refinement"extra"density"was"located"in"the"binding"region"
of" GSH." This" could" not" be" interpreted" by" the" protein" chain" and"was" hence" fitted" by" a"
102"
"
tartrate" molecule" originating" from" the" crystallization" condition." It" occupies" almost" the"








As" a" member" of" the" glutathioneUSUtransferase" family," PA1623" is" expected" to" bind"
glutathione" (GSH)." Binding" affinities" for" both" reduced" (GSH)" and" oxidized" glutathione"






Binding" affinities"were"determined" for" reduced" glutathione" and"oxidized" glutathione" to"




placed" four" molecules" in" the" asymmetric" unit," forming" two" dimers." The" structure" was"
refined" to" a" resolution" of" 1.30" Å" with" values" of" 11%" and" 14%" for" Rwork" and" Rfree,"
respectively" (table" 32" and" 33)." During" refinement" clear" additional" electron" density"was"
observed" in" all" four"monomers." Surprisingly," this" could" not" be" interpreted" by" only" one"
glutathione"molecule"but"two"molecules"per"monomer"fit"the"density.""
The" glutathione" molecules," bound" in" an" extended" manner" are" stabilized" by" a" large"
number" of" hydrogen" bonds."Main" contributing" parts" are" the" loop" region" connecting" β2"
and"β3"including"α2"of"the"NUterminal"domain"mediates"contact"with"the"first"glutathione"
molecule" (figure" 58)." The" side" chains" of" residue" K14," E67" and" S68" as" well" as" water"
molecules"bind"the"terminus"of"gammaUglutamylUmoiety."The"backbone"carbonyl"of"P53"
and" the" amide" of" I52" keep" the" cysteinyl" part" in" place," while" Q38" and" an" extended"
hydrogen" bond" network" spun" up" by" R51," K39" also" involving" the" second" glutathione"








The" second" GSH" is" bound" in" an" antiparallel" manner." The" negatively" charged" gammaU
glutamyl"moiety" is" stabilized"by" a" salt" bridge" to" an" arginine" residue," located"on" the"α1’"
helix"of"the"other"subunit."The"proteinUinside"facing"glycinyl"part"is"hold"into"place"by"N11"
and" three" water" molecules." In" addition" to" water" molecules" that" fund" the" majority"
mediating" contact" between" this" glutathione"molecule" and" the"protein" backbone," a" few"
hydrogen"bonds"between"the"GSH"molecules"are"observed."The"two"ligands"are"bound"in"
a"crevice"at" the" interface"generated"by"both"subunits"of" the"protein"dimer" (figure"58B)."
This"renders"the"enzyme"not"a"regular"glutathione"transferase"with"activity"in"stage"II"of"
cell" detoxification" but" rather" makes" a" different" function" likely." Despite" the" fact" that"
PA1623"was"crystallized"with"reduced"GSH"the"oxidized"form,"GSSG"was"bound"to"it."This"
suggests" that" the" protein"might" be" possess" disulfideUoxidoUreductase" activity" similar" to"
thioredoxin" (Aslund" et" al.," 1997)" or" glutaredoxin" (VlamisUGardikas" et" al.," 1997)."
Recently," Armstrong" and" coworkers" reported" an"oxidoreductase"mechanism," related" to"
that" of" glutaredoxin" 2" for" two" homologous" E.* coli* proteins" (Wadington" et" al.," 2009;"
Stourman" et" al.," 2011)" (figure" 59A)." A" superposition" of" both" with" the" PA1623UGSSG"
complex"revealed"a"remarkable"structural"similarity"with"rmsd"values"of"0.55"Å"and"0.72"
Å,"respectively."However,"YfgU"(PDB:"3C8E)"comprises"NU"and"CUterminal"extensions"which"
are" not" present" in" the" Pseudomonas" protein" but" YfcG" (PDB:" 3GX0)" shows" an" almost"
identical"fold"(figure"59B).""
Figure' 59:' Proposed' mechanism' of' PA1623' following' an' oxido8reductase' mechanism' (A)' (Stourman' et' al.,' 2011)'




Following" this" mechanism" PA1623" was" tested" with" the" model" substrates" diU(2U





































supported" by" water" molecules" allows" directly" access" to" the" tripeptide" only" via" the"
negatively"charged"tunnel"of"about"10"Å"lengths"(figure"64B)."The"tunnel"originates"from"a"












Knowledge" about" structure" and" function" of" GSTs" was" mostly" gained" in" the" past" by"
investigations"carried"out"on"animal,"human"and"plant"representatives"of"the"family."Only"
in" recent" years" along" with" wide" genome" sequencing," the" focus" of" GSTUresearch" was"
extended" to" bacterial" members." Hence," a" wide" diversity" in" GSTs" was" identified" and"
discovered" isoUforms"were"grouped" into"16"different"protein" classes,"historically"named"
by" Greek" letters:" α," β," δ," κ," µ," λ," ε," ω," ϕ," π," σ," θ," τ," ζ" and" recently" ν" and" η" class." The"







above." Until" today" six" different" classes" of" soluble" GSTs" are" known" to" exist" in" bacteria,"
namely"the"β,"χ,"θ,"ζ,"ν"and"η"class"(Allocati"et"al.,"2009;"Stourman"et"al.,"2011;"Skopelitou"
et" al.," 2012)." According" to" sequence" alignments" and" structural" comparison" it" has" been"
attempted"to"assign"PA1623"to"one"of"the"classes."
BetaUclass"enzymes"have"a"common"cysteine"residue"at"the"active"site"and"show"activity"








example" on" dichloromethane" (Vuilleumier" et" al.," 2001)." They" use" a" serine" residue" to"




Zeta" class" enzymes" have" been" identified" to" be" involved" in" tyrosine" as" well" as"
phenylalanine" catabolism" via" homogentisate." They" catalyze" the" penultimate" step," an"
isomerase" reaction" with" the" substrates" maleylacetoactetate" and" maleylacetone," which"
are" converted" into" fumarylacetoacetate" and" furarylaceton," respectively" (EC:" 5.2.1.2)"
(Blackburn" et" al.," 1998;" FernándezUCañón" &" Peñalva," 1998;" Cornett" et" al.," 1999)." In"
particular,"this"class"is"characterized"by"a"distinctive"motive"in"the"GSHUbinding"domain"(GU
site)," a" double" serine" followed" by" cysteine" residue" which" are" involved" in" the" catalytic"
mechanism"(McCarthy"et"al.,"1996)."Despite"automated"homology"annotation"suggests"an"
isomerase" activity" for" PA1623" following" the" zeta" class" mechanism," PA1623" does" not"
comprise"the"exclusive"motive"present"in"zeta"class"members.""
Recently," the" eta" (η)" class" (Skopelitou" et" al.," 2012)" was" reported" for" a" GST" from"
Agrobacterium*tumefaciens."In"this"protein"class"the"polar"catalytic"residue"is"replaced"by"
a" hydrophobic" loop" region" comprising" a" glycineUleucineUalanine" motive." Although"
structurally" similar," PA1623" is" also" not" a"member" of" this" class," according" to" active" site"
classification.""
The" nuUclass" (ν)" enzymes" have" a" threonine" residue" at" the" active" site."Members" of" this"




would" suggest" a" membership" of" the" nu" class." Structural" comparison" revealed" a" very"
similar"fold"of"PA1623"to"YfcG"with"an"r.m.s.d."of"0.55"Å"as"well"as"a"similar"binding"mode"
for" two"glutathione"molecules."A" sequence"alignment"of" the"active" site" containing" loop"
showed"only"a"difference"in"one"amino"acid,"namely"alanine"(A8)"of"YfcG"is"replaced"by"a"
proline"residue"in"PA1623."Overall"sequence"identity"of"PA1623"to"YfcG"is"46%"and"39%"to"
YghU," disregarding" YghU’s" NUterminal" extension" not" present" in" PA1623." Furthermore,"
YghU" shows" an" inserted" amino" acid" sequence" of" seven" amino" acids" in" the" CUterminal"








In" addition" to" sequence" alignments," a" DALI" (Holm"&" Rosenström," 2010)" and" PDBeFold"
(Krissinel"&"Henrick,"2004)"search"for"structural"homologs"was"performed,"using"a"single"




family;" GSTs" from" Xenorhabdus* nematophila" and" Pseudomonas" putida," with" r.m.s.d."
values"of"1.3"Å"and"1.1"Å"and"total"QUscores"of"0.77"and"0.69,"respectively,"both"deposited"
by"structural"consortia"without"a"related"publication."
Concluding," PA1623" from" Pseudomonas* aeruginosa" is" a" member" of" the" family" of" the"
soluble"GSTUlike"fold"proteins."The"nuUclass"protein"family"is"the"most"suited"class"for"this"
protein" as" revealed" by" sequence" and" structural" comparison." The" protein" binds" two"
molecules"GSH"as"well"as"GSSG"with"high"affinity"and"protects"the"reactive"thiol"groups"of"
the" tripeptides" by" an" arginine" residue" (R51)," keeping" the" oxidized" glutathione" in" place."
The"CUterminus"of" the"protein"generates"a" lid"on"top"of" the"active"site"and"at" the"same"




The" most" homologous" structure" is" the" protein" YfcG" (Wadington" et" al.," 2009)" from"












the" protein" to" translocation" to" the" periplasm" via" the" general" secretory" pathway" (SEC)."
Proteins"that"are"excreted"by"SEC"pathway"are"usually"translocated"in"an"unfolded"state"
(TullmanUErcek"et" al.," 2007)." This" indicated"already"a" challenge" for" soluble" recombinant"
protein"production"as"expressed"protein"could"be" insoluble"or" is"not"expressed"well."As"
signal"peptides"are"not"universally"recognized"amongst"species," the"Pseudomonas" signal"
peptide" might" not" be" recognized" by" the" E.coli" translocase," however," to" prevent" any"


























The" predicted" structural" motive" covers" amino" acids" 183U246" and" comprises" two" alpha"
helices" (α1" and"α2)" and" two"parallel" beta" sheets" (β1" and" β2)" (figure" 67)." The"model" is"
based"on"a"65" residues" stretch"of" the"uncharacterized"outer"membrane"protein" rv0899"
from"mycobacteria* tuberculosis" (Li" et" al.," 2012)" with" sequence" coverage" of" 24%" and"
identity"of"18%," respectively."The"model"belongs" to" the"OmpA" family;"PA1624"however"




























The" structure" was" solved" by" single" anomalous" diffraction" of" selenium" collected" at" the"
absorption"edge."Data"were"integrated"by"XDS"(Kabsch,"2010)"and"the"anomalous"signal"
extracted" by" SHELX" (Sheldrick," 2010)." The" located" heavy" atom" positions" were" used" as"
additional" input" file" for" AutoSol" (Zwart" et" al.," 2008;" Adams" et" al.," 2010)" carrying" out"
structure"solution."Manual"model"adjustments"were"done"by"COOT"(Emsley"et"al.,"2010)"
altering" with" automated" refinement" using" phenix.refine" (Adams" et" al.," 2010)." Data"
collection"and"refinement"statistics"are"shown"in"table"34"and"35.""
Table'34:'Data'collection'statistics'Data(collection( Δ18PA1624((native)(#ß( SAD[Δ18PA1624(#ß*(Detector( Rayonix(CCD( Pilatus(6M(Wavelength((Å)( 0.918( 0.979531(Resolution(range((Å)(+( 30(–(2.4((2.49(–(2.40)( 47(–(1.95((2.00(–(1.95)(Space(group( P212121( P212121(Unit(cell(parameters((Å;(°)( 54.42((58.81((163.4( 53.30((59.32((158.54(Total(No.(of(measured(reflections+( 78498((8666)( 3358272((58873)(Unique(reflections+( 21179((2202)( 37338((2498)(Multiplicity+( 3.7((3.9)( 89.9((23.6)(Anomalous(multiplicity( [( 46.5((12.2)(Mean(I/σ(I)(+( 4.6((1.5)( 20.3((2.0)(Anomalous(completeness((%)( [( 99.6((96.5)(Completeness((%)+(Average(Mosaicity(°(Matthews’(coefficient(
99.6((99.8)(0.333(2.37(




Table'35:'Refinement'statistics:'Due'to'better'data'quality'of'SeMet8dataset'the'native'data'was'left'unrefined.'Refinement(statistics( ( Seleno[(Δ18PA1624(Resolution((Å)(+( ( 47(–(1.95((2.00(–(1.95)(
Rwork((%)+(
















the" first"175"amino"acids," is" connected"by"a" linker"of" ten"amino"acids" to" the" smaller"CU
terminal" domain" consisting" of" 82" amino" acids." Both" domains" include" alphaUhelical" (in"
order" of" primary" sequence" NU6U8U12U14U16UC)" and" betaUsheet" (in" order" of" primary"
sequence"NU1U2U3U4U5U7U9U10U11U13U15U17U18UC)"secondary"structure"elements"(figure"70).""
The" first" 36" amino" acids" do"not" show"any" significant" secondary" structure," however" are"
stabilized"by"hydrophobic"interaction"with"a"long"helix"(α1)"covering"amino"acids"88U102"of"




motive" from" the" main" core" structural" element," an" arrangement" of" 6" antiparallel" beta"
sheets,"clamped"between"the"two"helices"and"the"thumb"motive."First"a"prominent"large"
beta" sheet" (β5)" twists" across" the" domain" core" followed" by" the" longest" helix" of" the"
structure" (α1)" which" is" clamped" between" the" NUterminus" as" described" above" and" the"
smaller"CUterminal"domain."
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The" NUterminal" alpha" helix" (α3)" and" the" following" beta" strand" (β10)" are" spanning" the"




the" terminal" arginine" residue," nicely" resolved" in" the" electron" density." The" overall"







terminal' core'with' rather' increased' (blue8green'color)' flexibility' in' the'smaller'C8terminal'domain.'The'N8terminus'







most" gramUnegative" bacterial" exclusive" restricted" to" the" periplasmic" space," PA1624"
however," was" express" in" the" reducing" environment" the" cytoplasm." Therefore," the"
formation"of"the"stabilizing"bond"must"have"happened"during"purification.""
The" two"monomers"within" the" unit" cell"make" crystal" contacts" via" the" interaction" of" 15"







al.," 1997)" querying" the" nonUredundant" database" excluding"Pseudomonas* species" (taxid:"
286)" revealed" that" this" protein" seems" to" be" only" conserved" amongst" the" originating"
species"Pseudomonas*as"no"significant"sequence"homology"was"found"the"NCBI"database."
Comparing" the" total" scores," judged" by" NCBI" the" protein" with" the" highest" identity" not"
120"
"




using" searching" with" PDBeFold" with" default" acceptable" matches" (Krissinel" &" Henrick,"
2004;"Krissinel,"2007)."Even"if"the"scoring"rate"was"reduced"to"50%"acceptance"no"match"

















al.," 2000;"Winsor" et" al.," 2011)." The"open" reading" frame" (6198055"–" 6198912," +" strand)"



















Figure' 75:' Predicted' domain' assignment.' The' putative' active' site' residues' of' the' C8terminal' are' marked' with' a'
triangle.''
A"sequence"similarity"search"against"the"nonUredundant"protein"database"of"NCBI"carried"
out"with"HMMER" (Finn" et" al.," 2011)" identified" ~500" homologous" sequences"with" an" EU
value" <" eU30." PA5506" is" highly" conserved" amongst" Pseudomonas" species." Several"
homologous" sugar" isomerases" (SIS)" families"were" identified"which" are" either" individual"
proteins"or"a"domain"of"larger"protein."Most"similar"proteins"are"members"of"the"RpiRUlike"
transcription" regulator" family." HMMER" identified" two" structurally" characterized" close"
homologs"of"P5506"within"the"PDB"(Bernstein"et"al.,"1977)."One"hit"covers"the"exact"two"
domain" query" architecture" (table" 36)" and" the" second" only" the" SIS" domain." Both" are"
members"of" the" transcription" regulator"proteins"originating" from"Vibrio* vulnificus" (PDB:"







PDBUID" Description" Origin" EUvalue" Coverage"









3FXH" Integron"cassette"" Vibrio*cholera* 0.7" HTHUdomain"
"
5.4.2. PA5506&–&structural&prediction&&
Results" from" sequence" analysis" indicate" that" PA5506" is" a" member" of" the" RpiRUlike"
transcription"factor"family."So"it"was"not"surprising"that"results"from"structural"prediction"
using"PHYRE"revealed"the"already" identified"transcription"factor" (PDB:"4IVN)"as" the"best"
homologous"model"for"PA5506"with"a"TM"score"of"1.0"followed"by"the"SIS"domain"of"the"























Molecular" replacement" either" employing" either" the" transcription" regulator" structure"
(PDB:"4IVN)"or"single"sugar"isomerase"domains"as"search"model"was"not"successful."A"high"
redundant"dataset,"initially"collected"for"a"sulfur"SAD"approach,"indicated"the"presence"of"
a" stronger" anomalous" scatterer" stronger" than" sulfur" bound" to" the" protein," possibly" a"
metal" (data"not" shown)."This"was"confirmed"by"an"extended"XUray"absorption" structure"









Two" datasets" collected" around" the" zinc" edge" showed" presence" of" anomalous" signal" in"
data"collected"at"high"energy"remote"and"the"absence"of"it"below"the"edge"(table"38)."As"





Located" heavy" atom" sites" (Sheldrick," 2010)" were" used" as" additional" input" for" AutoSol"






Data"collection" SADUPA5506#*" PA5506#*$"peak" PA5506"infl.#*$"
Detector" Pilatus"6M" Pilatus"6M" Pilatus"6M"







Space"group" P41212" P212121" P212121"




Unique"reflections+" 34127"(2268)" 38830"(3311)" 15511"(2451)"
Multiplicity+" 12.7"(13.3)" 26.6"(27.6)" 12.3"(12.8)"
Anomalous"multiplicity+" 6.6"(6.8)" 13.9"(14.4)" 6.6"(6.7)"
Mean"I/σ(I)"+" 18.5"(2.3)" 17.8"(4.0)" 10"(3.5)"
Anomalous"completeness"(%)" 99.8"(100)" 100"(100)" 99.8"(98.7)"









Average"Mosaicity"°" 0.13" 0.07" 0.17"
Rmerge+"(%)" 10.2"(141)" 16.2"(126)" 25.5"(116)"
Rmeas‡"(%)" 10.6"(152)" 16.5"(126)" 26.7"(121)"
Rpim$"(%)" 3"(41.4)" 3.2"(23.9)" 7.7"(34.4)"




















Data"collection" PA5506"Zn"hrem"#*ρ" PA5506"Zn"lrem"#*ρ" Native"PA5506#"
Detector" Pilatus"6M" Pilatus"6M" Pilatus"6M"







Space"group" P212121" P212121" P41212"




Unique"reflections+" 38723"(3299)" 35850"(3242)" 30325"(2107)"
Multiplicity+" 11"(10.4)" 7.1"(6.8)" 7.2"(7.4)"
Anomalous"multiplicity" 5.8"(5.4)" 3.7"(3.5)" UU"




Completeness"(%)+" 99.9"(99.9)" 99.5"(95.7)" 100"(100)"









Rmerge+"(%)" 14.7"(102)" 10.7"(72.7)" 6.7"(103.2)"
Rmeas‡"(%)" 16.1"(113)" 12.4"(85.5)" 7.2"(110.9)"
Rpim$"(%)" 6.5"(34.9)" 5.6"(32.6)" 2.7"(40.4)"

























Space"group" P41212" P212121" P41212"
Rwork"(%)+" 17.2"(25.6)" 19.6"(26.6)" 20.0"(28.3)"




""""Protein" 2944" 5751" 2823"
""""Water" 186" 87" 72"
#"chains"/"ASU" 2" 4" 2"
Matthews"coefficient" 2.31"≘"46"%"solvent" 2.18"≘"43"%"solvent" 2"≘"46%"solvent"
Average"BUfactors"(A²)" 36.7" 47.1" 44.2"
""""Protein" 36.6" 47.0" 44.4"
""""Water" 37.6" 37" 37.7"
R.m.s."deviations" " " "
""""Bond"lengths"(Å)" 0.009" 0.004" 0.003"
""""Bond"angles"(°)" 1.07" 0.79" 0.73"
Ramachandran"plot"!" " " "
"""Favored"regions"(%)" 98" 98" 97.5"
"""Outlier"(%)" 0" 0" 0.0"
Validation"score&" " " "
""""Clashscore" 2.4" 2.1" 1.08"











The* Pseudomonas* aeruginosa" PA5506" consists" of" 285" amino" acids." Past" data" collection"




(table"4)." Structural" inspection"after" initial" refinement" revealed" the" reason" for" incorrect"
assignment"of"the"Matthews"coefficient."Despite"the"fact"that"fullUlength"protein"was"used"















The" protein" content" of" isolated" and"washed" crystals" analyzed" by" SDSUPAGE" revealed" a"
lower"molecular"weight"of"around"20"kDa"(figure"82B)."To"identify"the"disposition"of"the"










the" cleavage" is" induced" by" components" of" the" mother" liquor" used" for" crystallization."
Hence,"a"comparative"gel"analysis"using"samples"of"both,"pure"native"and"SeMet"labeled"































Rfree," respectively." The" asymmetric" unit" of" the" P41212" crystals" contained" two" protein"












the" Ramachandran" plot" with" a" MolProbity" (Davis" et" al.," 2004)," used" for" structural"
validation"reported"score"values"of"around"1.2"(Chen"et"al.,"2010).""
The"overall"fold"of"the"protein"consists"of"a"parallel"5Ufold"beta"blade"which"is"clamped"by"









two" symmetrical" molecules" to" the" tetrameric" protein" structure." The" protein" assembly"
comprises"a"dimer"of"dimers"(chain"A"and"B"form"dimer"1"and"chain"C"and"D"form"dimer"2)"
related"by"a"twoUfold"axis"resulting"in"a"tetramer"with"222"symmetry."Each"monomer"has"






4500"Å²." The" interactions" between" the" two" dimers" AB" and" CD" are"mostly" hydrophobic"
with"only"a"few"hydrogen"bonds."The"buried"area"between"A/B"and"C/D"contributes"about"
twice"to"the"total"buried"area"of"the"tetramer."The"four"subunits"of"the"tetramer"within"








Extensive" hydrogen" bond" networks" as" well" as" 11" salt" bridges" stabilize" the" overall"
structural"conformation"(table"40).""
Table'40:'Analysis'of'engaged'interfaces''
##" Interfacing"structures" Buried"surface"[Å²]" "ΔiG"[kcal/mol]"" #"HB" #"SB"
1" A"+"B" 2699" U45.9" 13" 11"
2" C"+"D" 2697" U45.8" 6" 9"
3" A"+"D" 1198" U11.2" 4" 8"
4" B"+"C" 1159" U11.4" 5" 10"
5" ABCD" 26612" U163" U" U"
"




















significant" importance" and" be" caused" by" crystal" packing" artefacts." Furthermore," this"
terminus"will"in"the"fullUlength"protein"never"be"exposed"to"the"surrounding"environment.""
Alterations" on" the" CUterminus" are" more" relevant" as" terminal" residues," often" not"
considered" essential," have" been" shown" in" some" proteins" to" achieve" a" major" role" in"
regulation" of" the" enzyme." For" example," the" CUterminus" of" ERK5" a" unique" mitogenU
activated"protein" (MAPKs)"was" shown" to"be" involved" in" autoUinhibition"of" the"protein’s"




amongst" all" three" structures." The" homogenous" chain" branches" of" into" three" different"








In" contrast" to" a" homologous" SISUmember," the" sedoheptuloseU7Uphosphate" isomerase"
GmhA"from"Burkholderia*pseudomallei*which"binds"the"metal" in"the"‘heart"of"the"active"






























Moreover," tyrosine"192" flips"about"180°" into" the"center"of" the" tetramer"~18"Å" from" its"
original"position,"losing"hydrogen"bond"contacts"to"D215"and"the"backbone"of"S219."R190"
flips" in" the"close"conformation" into" the"position"previously"occupied"by"Y192."Secondly,"
the" overall" positioning" of" the" CUterminus" is" different" (chain" C" and" D," figure" 18)." The"
conformation" in"the"open"state" is"stabilized"by" intramolecular"hydrogen"bonds"between"
the" side" chain" of" S280" and" main" chain" of" R275" as" well" as" water" mediated" contacts"
140"
"
between"the"side"chains"of"H281"and"R275."Histidine"281"(chain"C),"which" is" involved" in"













P212121" crystal," are" of" relevance" for" the" structural" changes." Not" observed" in" the" apo"
structure," one" phosphate" molecule" stabilizes" the" conformation" of" arginine" 191" by"
generating"a"hydrogen"bond"network"within"the"loop"region."Structural"comparison"with"a"
homologous" structure" from" Bacteroides* fragilis" (PDB" ID:" 3ETN)" (Chiu" et" al.," 2014)" and"
Pseudomonas* aeruginosa" (PDB" ID:" 1X92)" (Taylor" et" al.," 2008)," coUcrystallized" with" its"
phosphorylated" substrate," indicated" this" phosphate" as" putative" conserved"molecule." In"











numbers'and'those'of'the'homologous'structures'are'presented' in' italic' format,'S7P'='Sedoheptulose878phosphate'
and'ManNAc86P'='28(Acetyl8amino)828desoxy868O8phosphono8alpha8D8mannopyranose.''
"
The" phosphate" in" homologous" structures" is" coordinated"by" a" loop" connecting" β3" to"α6,"
previously"described"as"the"‘Ser/ThrUrich" loop’"(Chiu"et"al.,"2014)."This" loop"is"conserved"
amongst" arabinoseUphosphate" isomerases," however," is" replaced" by" the" ‘Tyr/ArgUswitch"
loop’" in" PA5506." Structural" reorganization" of" this" loop" is" crucial" for" completion" of" the"
active" site" (figure" 93A)" and" phosphate" binding" by" the" amide" backbone" of" S144," F143,"
R142,"R191"as"well"as"the"side"chain"of"R191"in"its"‘close’"conformation"(figure"94)."
"
Figure' 94:' Superposition' of' both' active' site' conformations.' The' phosphate' ion' is' bound' to' the' P212121' structure'





While" this" study"was" carried"out,"PA5506"was" identified"as"an"RpiRUfamily" transcription"
regulators"homolog,"named"qapR"(Tipton"et"al.,"2013)."It"regulates"the"expression"of"the"
qapUoperon" comprising" three" downstream" genes" PA5507," PA5508" and" PA5509* in" a"
negative"way" (Tipton"et" al.," 2013)."Deletion"of"PA5506" and" therefore"expression"of" the"
qapUoperon"results"in"decreased"level"of"PQS"which"subsequently"decreased"the"levels"of"
pyocyanin,"as"PQS"signaling"is"its"primary"regulator"(Blankenfeldt"&"Parsons,"2014;"Welsh"
et" al.," 2015)." The" PQS" molecule" as" a" positive" feedback" inducer" influence" on" its" own"
synthesis," thus" the" transcription" level" of" the" biosynthetic" operon" is" found" to" be"much"













follows" a" metal" catalyzed" reaction" mechanism" (Harmer," 2010)." Interestingly," the"
composition"of"the"CUterminus"of"PA5506,"which"is"involved"in"zinc"binding"was"identified"
as" unique" by" alignment" of" 1000" sequences." As" transcription" regulator," QapR" probably"
does"not"act"as"sugar"isomerases"but"rather"binds"a"certain"type"of"ligand"molecule,"which"

















The" protein" sequence" was" retrieved" from" the" Pseudomonas" Genome" Database" (PGD)"
entry" PA5507." The" hypothetical" cytosolic" protein" has" 31" putative" orthologs" among"
Pseudomonas*species*(Winsor"et"al.,"2011)"and*is"embedded"in"the"qapUoperon,"covering"
the"genes"PA5506KPA5509"(Tipton"et"al.,"2013)."Structural"prediction"by"PHYRE"(Kelley"&"




while'alpha'helical'part'a'stained' in'red.'The'C8'and'N8termini'of' the'predicted'protein'chain'are' indicated'with'C8
term'and'N8term,'respectively.'The'grey'dashed'line'connects'a'part'which'could'not'be'predicted'by'the'automated'
online'server'PHYRE'(Kelley'&'Sternberg,'2009).'
This" superfamily" covers" five" subclasses" of" which" the" NUcarbamoylsarcosine"
amidohydrolase" (CSHase)" proteins" are" involved" in" creatinine" catabolism" (Wyss" &"
KaddurahUDaouk,"2000)"and"members"of"the"nicotinamidase"family"converts"nicotinamide"
into" nicotinic" acid" and" ammonia" (Lemaitre" et" al.," 2001;" Smith" et" al.," 2011)." The" third"
family"member"are"the"isochorismatases"that"catalyze"the"conversion"of"isochorismate"to"
2,3UdihydroxyU2,3Udihydrobenzoate" and" pyruvate" via" hydrolysis" of" a" vinyl" ether" bond"
(Parsons" et" al.," 2003)." Last," the" nicotinamidaseUrelated" proteins," possessing" the" same"
catalytic" triad" than" nicotinamidases" hence," do" not" convert" nicotinamide." Finally," the"
family" of" YcaCUlike" proteins" that" shares" a" high" homology" to" the" hydrolase" YcaC" from"





conserved" cisUpeptide" bond" in" the" CUterminal" part" of" the" protein." This" conformation"
allows" the" generation" of" an" oxyanion" hole" to" stabilize" the" intermediate" state" of" the"
substrate"conversion"during"catalysis"as"it"is"part"of"a"predicted"catalytic"triad:"D25,"K123"
and"the"C156"(MarchlerUBauer"et"al.,"2013)."Concluding"here,"PA5507"is"a"member"of"the"






































The" phase" problem" was" solved" by" molecular" replacement" (MR)" using" the" automated"
pipeline"BALBES"(Long"et"al.,"2008)."Structure"solution"revealed"two"amino"acid"chains"in"
the"asymmetric"unit" forming"a"homodimer."The"Matthews"coefficient"was"calculated" to"













Number"of"reflections" " 80342"(7918)" "
































similar" to" the" 3Ulayer" ’alphaUbetaUalpha" sandwich" family’," with" the" characteristic"
organization"of" 6"parallel" twisted"βUsheets" clamped"with" flanking" alpha"helical" bundles."
 
Figure'98:'Two'chains'occupy'the'asymmetric'unit'of'the'crystal.'Chain'B'is'stained'in'pale'green'and'chain'A'in'green'




The"dimer" interface"between"the"two"chains" is" realized"by"parallel"crossUspanning"alpha"
helices"of"each"subunit"creating"a"mostly"polar"protein"dimer"interface."In"fact,"analysis"of"
crystal" packing" revealed" a" protein" tetramer," which" is" assembled" by" chains" from" two"
neighboring" asymmetric" units." This" is" in" congruence" with" results" from" size" exclusion"
chromatography"indicating"a"higher"molecular"weight."
PISA" analysis" (Krissinel" &" Henrick," 2007)" predicted" a" solventUaccessible" surface" area" of"





Figure' 99:' SAXS' data' fitting.' A' calculated' scattering' curve' of' a' molecule' (red' line)' is' fitted' with' experimental'




To" exclude" a" concentration" dependent" oligomerization," five" individual" datasets" were"
collected"with"different"protein"concentrations."Even"at"very"low"concentration"the"stable"

















other," respectively" (figure" 8A)." Due" to" the" high" flexibility," this" regions" linker" was" not"
completely" traceable" in"both" subunits" and"could"not"be"modeled" in" chain"B"due" to" the"
lack" of" electron" density." Super" positioning" of" individual" chains" reveals" that" this" loop"








Closer" inspections" of" the" loop" region" revealed" an" aspartic" acid" and" a" histidine" residue"












Figure'104:'PA5507'monomer' (A)' the' flexible'part' completing'and'closing' the'active'site' is' shown' in' red' (10A'and'






which" is" supported" by" lysine" 122," acting" as" a" general" base." This" hypothesis" is" strongly"
supported" by" our" crystallographic" data." During" refinement" additional" electron" density"
which" could" not" be" interpreted" by" the" polypeptide" chain" was" observed," suggesting" a"
covalently"attached"modification"at"the"C156"which"can"neither"be"explained"by"oxidation"






Results" from" structural" searches" selecting" only" cysteine" hydrolases," PDBeFold" and"DALI"
both" indicated" a" cysteine" hydrolase" from" Pseudomonas* syringae," (pdb:" 3IRV)" as" most"
homologous" structure" apart" form" nicotinamidases" that" are" also" revealed" as" close"
homologous"members."This"protein" family,"however," involves"a"metal"dependent" ligand"
binding"either"using" zinc" (pdb:"2wt9)," (Fyfe"et" al.," 2009);"2h0r," (Hu"et"al.," 2006);" " 3o92,"
(French" et" al.," 2010);" 3s2s," (Liu" et" al.," 2011)" or" iron" (pdb:" 3pl1," (Petrella" et" al.," 2010),"
respectively." Because" PA5507" lacks" the" histidine" residues" involved" in" metal" binding," a"
metal"independent"reaction"mechanism"must"be"employed"and"therefore"PA5507"can"be"
excluded" from" this" family." Third"a" characterized"NUcarbamoyl" sarcosine"amidohydrolase"
(pdb:"1NBA,"(Romão"et"al.,"1992))"was"identified"by"DALI"search."Active"site"residues"are"
located" at" but" the" surrounding" active" site" environment" is" different." The" NUcarbamoyl"
sarcosine"hydrolyzing"enzyme"provides"polar"contacts"with"close"proximity"of" the"active"
cysteine."The"active"site"of"PA5507,"however,"is"clearly"divided"in"two"parts,"the"side"close"











Figure'106:'Enzyme8coupled'assay'to'test'amidase'activity.'The'blue' line'represents'a' ‘buffer8only’'control;' the'red'




PA5507" is" as"member"of" the"qapUoperon"coUtranscribed"with"a" characterized"glutamine"
synthetase" homolog" (Ladner" et" al.," 2012)" and" a" putative" NUformyl" glutamate"
amidohydrolase," PA5509." The" operon" was" suggested" to" be" metabolizing" either" PQS"
(figure" 14)," an" important" Pseudomonas" specific" secondary" metabolite" or" one" of" its"
precursor"molecules"(Tipton"et"al.,"2013).""
"""""" "
Figure'107:' Chemical' structure'of' PQS' (Pseudomonas' quinolone' signal)' and' its' direct' chemical' precursor'molecule'
HHQ'(28heptyl848quinolone).'




Concluding," the" structure" of" PA5507," a" member" of" the" cysteine" hydrolase" superfamily"
could" be" solved" in" this" study." An" unidentified" covalent" modification" of" the" active" site"













Pseudomonas* aeruginosa* is" a" versatile" opportunistic" human" pathogen" with" a" rising"
number"of"antibiotic"multidrug"resistant"strains."It"can"cause"severe"infections,"especially"
to" individuals" in" hospital" environments" where" inappropriate" therapy" readily" selects"
antibiotic" resistant" strains" against" which" only" a" minor" number" of" efficient" agents" are"





that" might" be" used" as" new" drug" targets" must" be" hidden" within" the" large" number" of"
uncharacterized"gene"products."
In"this"work,"results"achieved"during"the"pilotUphase"of"a"new"structure"based"approach"
with" follow" up"metabolomic" analysis," to" elucidate" previously" uncharacterized" operons,"
are" presented." Two" operons" were" selected," both" comprising" four" previously"
uncharacterized" genes." Selected" gene" clusters" PA1621UPA1624" and" PA5506UPA5509"
which"was"termed"“qapUoperon”"(Tipton"et"al.,"2013)"were"structurally"elucidated"at"the"




Structural" characterization" of" PA1622" revealed" a" protein" with" an" alpha/betaUfold"
(PA1622)" comprising" an" active" site" featuring" a" classical" serine" peptidase" triad," with" an"
overall" fold" very" similar" to" a" previously" reported" thioester." During" refinement" of" the"
structure,"additional"electron"density"was"identified"in"the"active"site"pocket,"indicating"a"
ligand" molecule" covalently" bond" to" the" active" site" serine." Due" to" weak" signal" for" the"
ligand,"an"identification"was"not"possible."However,"a"compound"composed"of"a"minimum"
number"of"15"nonUhydrogen"atoms"is"proposed.""
PA1623" was" predicted" to" be" a" protein" with" glutathioneUSUtransferase" activity." As" the"
structure"was" determined" it" turned" out" that," instead" of" one" glutathione"molecule," the"
158"
"
protein" had" specifically" bound" two" molecules" of" glutathione" in" the" active" site." Many"
structures"have"been"reported"that"share"the"same"typical"GSHUfold"as"PA1623,"yet"this"is"
the"first"one"amongst"the"nuUclass"with"a"structurally"resolved"CUterminus,"which"might"be"
involved" in" regulation"of" the"protein’s" activity." The" ligand"bound" structure" indicated"an"
involvement"of"the"CUterminus"as"it"restricts"the"access"to"the"putative"active"sulfur"atom"
of"the"bound"GSH"molecule."""
The" third" determined" structure" is" that" of" the" periplasmic" protein" PA1624." Amongst" all"
structures" deposited" to" the"PDB," no" similar" fold" could" be" identified"which" renders" this"
protein"unique.""
Genes"coded"in"the"‘qapUoperon’"were"shown"to"have"a"negative"effect"on"concentration"
levels" of" PQS," an" important" second" messenger" involved" in" quorum" sensing" in"





metal" binding" site." It" was" shown" that" a" reorganization" of" the" ‘Tyr/ArgUswitch" loop’" is"
necessary" to" complete" the"putative" active" site." Comparison" to" structural" homologs," coU
crystallized" with" their" phosphorylated" substrates," revealed" a" conserved" phosphate"
position" in"the"active"site"that"occupied"an" identical"position."This"suggests"that"PA5506"
also" binds" phosphorylated" compounds," and" in" particular" phosphorylated" sugar"
compounds" as" it" shows" strong" structural" as" well" as" moderate" sequence" homology" to"
members"of"the"sugar"isomerase"super"family.""
PA5507"was"predicted"as"a"protein"with"homology"to"members"of"the"cysteineUhydrolase"
family." The" structure" revealed" a" protein"with" an" amidase" fold" employing" a"HisUCysUAsp"
catalytic" triad." Closer" inspections" of" the" active" site" identified" uninterpretable" electron"
density,"which"was" assigned" to" a" ligand" that"was" covalently" attached" to" the" active" site"

















operon" (Tipton" et" al.," 2013)" and" three" coded" on" the" second" selected" operon." Hence,"
structural"determination"of" the"proteins"PA5509"and"PA1621"would"be" the"next"step" in"
order"to"complete"both"operons.""
PA5506," the" transcription" regulator" of" the" qapUoperon," already" partially" characterized"
would"be"the"starting"point"for"further"experiments"to"first"identify"the"regulating"ligand,"
a"putative"phosphorylated"sugar."First,"metal"binding"of"the"protein"should"be"verified"by"
using" for" example" calorimetric" methods," also" photometric" methods" like" fluorescence"
titration"could"be"used"since"at" least" four" tyrosine" residues"are"changing" their" chemical"
environment" upon" hypothetical" metal" binding" as" revealed" in" this" study." Furthermore,"
once" this" question" is" answered" experiments" to" identify" its" ligand" are" suggested" to" be"
carried"out,"employing"first"binding"studies"in"the"presence"and"absence"of"zinc"to"identify"
potential" binds" ligands." This" is" then" followed" by" xUray" crystallographic" methods" by"
attempting" either" soaking" or" coUcrystallization" with" the" putative" previously" identified"
ligand." Third," if" the" ligand" is" identified," the" problem" of" protein" degradation" should" be"
elucidated." Tipton" and" coworker" identified" a" DNA" stretch" which" PA5506" seems" to"
selectively" recognize" (Tipton"et"al.,"2013)."This"oligonucleotide" fragment" is" suggested" to"
be"used"in"coUcrystallization"attempts,"because"crystallization"in"complex"with"DNA"might"
prevent"the"NUterminal"domain"from"degradation."
However," the" main" goal" of" further" studies" would" be" the" assignment" of" substrate" and"
product" for"each"operon."Therefore,"metabolite"extracts"of"generated"operon"knockout"
mutants" need" to" be" analyzed" in" a" comparative" metabolomic" approach." Observed"
differences" in" metabolome" composition" amongst" knockout" vs." wild" type" vs." gainUofU
function" mutant" might" lead" to" a" putative" substrate/product" pair," metabolized" by" the"
operon,"and"a"general"function"assigned."Combining"this"with"structural"knowledge"of"all"
single"gene"products"with,"a" functional"hypothesis" for"every"protein"could"be"proposed."
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9.  Appendix 















9.3 Structural prediction 
Table 434: Results for all protein sequences using the Phyre prediction server (Kelley & Sternberg, 2009); the five best 
hits are listed descending from top for all five proteins.  PDB ID  Description Sequence coverage Sequence identity 
PA5506  88%  4IVN transcriptional regulator 95% 24% 3SHO transcriptional regulator, rpir family 60% 24% 3FXA sis domain protein 58% 15% 2XHZ arabinose 5-phosphate isomerase 61% 14% 3ETN putative phosphosugar isomerase involved in capsule 60% 16%     
PA5507  94%  2FQ1 non-ribosomal peptide synthetase  entb 98% 24% 1NBA Isochorismatase-like hydrolases 91% 26% 1NF9 Isochorismatase-like hydrolases 94% 24% 3IRV cysteine hydrolase pspph_2384 96% 28% 1J2R Isochorismatase-like hydrolases 90% 21%     
PA1622  95%  1CR6 epoxide hydrolase 98% 19% 3I28 epoxide hydrolase 2 99% 18% 1AZW Proline iminopeptidase-like 97% 18% 4QLO homoserine o-acetyltransferase 96% 12% 4D9J 16nm tetrahedral protein cage containing non-haem 96% 12%     
PA1623  95%  3C8E yghu, glutathione s-transferase homologue 94% 38% 4ECJ glutathione s-transferase prk13972 91% 100% 4MZW nu-class glutathione transferase 92% 43% 3GXO gst-like protein yfcg - oxidoreductase 90% 47% 4IKH Glutathione transferase – Ps.fluor. pf-5 90% 49%     


















9.4 Protein expression and purification 
 
9.4.1 PA5506 expression and purification 
The 285 amino acid protein PA5506 was expressed as an N-terminal His6-tagged fusion 
protein. Typical affinity chromatography, tag cleavage and gel filtration yielded pure 
protein. A final yield of 4 mg of >95% pure native protein per liter of culture and 1 mg per 
liter in the case of selenomethionine labeled protein expression could be obtained. The 




Figure 109: Left: SDS-PAGE analysis of SeMet PA5506 (32.3 kDa) after size exclusion chromatography, right native 
labeled protein. Marker includes proteins of 116, 66, 45, 35, 25, 18, 14 kDa size. 
 
9.4.2 PA5507 expression and purification 
PA5507, a 24 kDa protein was expressed as His6-tagged SUMO fusion protein from a 
pOPINE vector (Berrow et al., 2007), cloned by DFP (http://www.dpf.mpi-
dortmund.mpg.de/) (Oliner et al., 1993; Li & Elledge, 2007). Nickel-affinity 
chromatography, tag cleavage by SUMO-protease and size exclusion chromatography 
yielded 15 mg pure protein per liter of cell culture. PA5507 eluted from a Superdex 200 
HP 26/60 as a single peak with a retention volume of 145 ml at peak maximum. The 
calculated mass of the protein is in the range of 100 to 110 kDa, indicating that the 
protein associates as tetramer in solution. About 15 mg of pure protein, according to 
Commassie stain were obtained from 1 liter cell culture. The protein was concentrated to 
22 mg/ml prior to crystallization experiments. 
 
9.4.3 PA5508 expression and purification 
The glutamine synthetase (GS) homologue PA5508 was expressed from p10$ and purified 
by nickel affinity followed by typical tag cleavage. A yield of 6 mg/liter pure protein could 
be obtained after size exclusion chromatography. In order to elute PA5508 from the 
nickel column 500mM imidazole was supplied to the column. During gel filtration the 
protein eluted almost within the void volume as indicating a complex of large size.  
 
9.4.4 PA1622 expression and purification 
The putative enzyme PA1622 was expressed as N-terminal T7-lysozyme fusion from p10$. 
Nickel affinity chromatography and gel filtration yielded 12 mg of >95% pure protein per 
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liter cell culture in native conditions. 8 mg per liter were obtained when expressing the 
selenomethionine labeled protein. 
  
Figure 110: Left: SDS-PAGE analysis of native PA1622 (31.2 kDa) after size exclusion chromatography, right SeMet 
labeled protein. Marker includes proteins of 116, 66, 45, 35, 25, 18, 14 kDa size. 
   
9.4.5 PA1623 expression and purification 
The N-terminal GFP tagged PA1623 was purified by standard 2 step nickel affinity 
chromatography followed by size exclusion purification step. The finally obtained protein 
was >95% pure with a yield of 10 mg when expressing native protein and 8 mg of 




9.4.6  PA1624 expression and purification 
The predicted periplasmic protein was expressed from p10$ as an by signal peptide 
truncated (amino acid 1-18) N-terminal tagged fusion protein. Purified by metal affinity- 
and polished by size exclusion chromatography, 8 mg >95% pure native and 4 mg 
selenomethione labeled protein were yielded per liter cell culture. 
 
Figure 111: Left: SDS-PAGE analysis of native Δ18PA1624 (27 kDa) after size exclusion chromatography, right SeMet 
labeled protein. Marker includes proteins of 116, 66, 45, 35, 25, 18, 14 kDa size. 
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  Crystallization 
 
9.4.7 Screening and optimization 
From initial crystallization screen various conditions were identified to yield protein 
crystals. Several crystal shapes and sizes were obtained from which conditions yielding 
the best diffracting crystals were optimized in a two-dimensional grid screen manner. 
Improved size and shape was reached by varying the pH of buffer solution as well as the 
precipitant concentration of this condition. Thus, the protein concentration was also 
altered by setting up multiple drops within one condition. In table 45 are final mother 
liqour compositions summarized. 
Table 44: Final mother liquor composition, protein concentration and cryo protecting agent Protein Mother liquor composition Protein concentration Cryo protection (mother liquor) PA1622 native 0.24 M magnesium formate  22% PEG 3350 20 mg/ml + 20% PEG 400 PA1622 SeMet 0.1M HEPES pH7 5% PEG 6000 10 mg/ml + 20% glycerol     PA1623 native 0.1 M BisTris pH 6.5    0.1 M sodium potassium tartrate 22 % PEG 3350 15 mg/ml + 20% PEG400 PA1623 SeMet 0.1 M BisTris pH 6.7     0.1 M sodium potassium tartrate 18 % PEG 3350 14.5 mg/ml + 22% glycerol     PA1624 native 0.1 M MES pH 6 0.2 M Calcium acetate 20% PEG 8000 15 mg/ml + 20% glycerol PA1624 SeMet 0.12 M tri-sodium citrate pH 5.5 0.2 M ammonium acetate 30% PEG 4000 20 mg/ml + 20% PEG 400     PA5506 native 0.2 M sodium chloride 10% PEG 3000 0.1 M sodium phosphate citrate pH 4.2  15 mg/ml + 22% PEG400 PA5506 SeMet 20% PEG 4000 0.2 M potassium fluoride 0.05 M KH2PO4 15 mg /ml + 20% PEG400     PA5507 native 0.26 M CaCl2  29% PEG 3350 10 mg / ml + 20% glycerol     PA5508 native 0.1 M MES pH 6.5 1.6 M Magnesium sulfate 4 mg/ml + 20% PEG 400 
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9.5 Fluorescence scan 
 
To define the exact energy of the incident beam needed to match peak and inflection 
point of the protein incorporated selenomethinone atoms an x-ray fluorescence scan was 
performed before every experiment. An example is shown in figure 112.  
 
Figure 112: Result of a typical x-ray fluorescence scan to determine energy for peak and inflection point of selenium 
atoms 
 
9.5.1 SAD phasing of PA5506/PA1622/PA1623/PA1624 
Phases of labeled proteins were obtained by single or multi wavelength anomalous 
dispersion experiment carried out at the selenomethionine absorption edge. SHELXC 
(Sheldrick, 2010) were used to extract the anomalous signal and SHELXD (Schneider & 
Sheldrick, 2002) to locate heavy atom positions which were used as additional input for 
the program AutoSol (Adams et al., 2010; Echols et al., 2012) carrying out model building 
and initial refinement. This phase information was then transferred to native data sets if 
beneficial. Refined model was then used as search model for molecular replacement to 
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solve the structures in different space groups. The graphical interface hkl2map was used 
to visualize phasing results (Pape & Schneider, 2004). 
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